Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	regulation of system process	FOXO1 CACNA1S ENPP7 ACACB LMCD1 SYNE1 TRPC1 APOA1 CHRM3 MEF2C RYR2 KCNG2 SLC8A2 PPP3CA KCNC4 AFDN CACNA1H DMD ATP2A3 EP300 WNK4	2.65e-06	734	184	21	GO:0044057
GeneOntologyBiologicalProcess	digestive system process	ENPP7 COPA TRPC1 VSIG1 APOA1 CHRM3 PPP3CA WNK4	1.77e-05	126	184	8	GO:0022600
GeneOntologyBiologicalProcess	cardiac muscle hypertrophy	FOXO1 ACACB LMCD1 MEF2C MEIS1 RYR2 PPP3CA EP300	4.18e-05	142	184	8	GO:0003300
GeneOntologyBiologicalProcess	striated muscle hypertrophy	FOXO1 ACACB LMCD1 MEF2C MEIS1 RYR2 PPP3CA EP300	5.09e-05	146	184	8	GO:0014897
GeneOntologyBiologicalProcess	striated muscle cell differentiation	SOX6 CACNA1S NRAP MYOM1 SYNE1 KAT2A MEF2C MEIS1 PPP3CA ALPK3 CACNA1H DMD EP300	5.19e-05	391	184	13	GO:0051146
GeneOntologyBiologicalProcess	muscle hypertrophy	FOXO1 ACACB LMCD1 MEF2C MEIS1 RYR2 PPP3CA EP300	5.61e-05	148	184	8	GO:0014896
GeneOntologyBiologicalProcess	megakaryocyte development	FLI1 MEIS1 NBEAL2 EP300	7.86e-05	26	184	4	GO:0035855
GeneOntologyBiologicalProcess	digestion	ENPP7 COPA TRPC1 VSIG1 APOA1 CHRM3 PPP3CA WNK4	9.69e-05	160	184	8	GO:0007586
GeneOntologyBiologicalProcess	muscle cell development	CACNA1S NRAP MYOM1 MEF2C MEIS1 PPP3CA TMTC3 ALPK3 DMD EP300	1.16e-04	259	184	10	GO:0055001
GeneOntologyBiologicalProcess	muscle system process	FOXO1 CACNA1S ACACB MYOM1 LMCD1 ARHGEF11 CHRM3 MEF2C MEIS1 RYR2 PPP3CA SLMAP CACNA1H DMD EP300	1.22e-04	547	184	15	GO:0003012
GeneOntologyBiologicalProcess	regulation of cardiac conduction	TRPC1 RYR2 SLC8A2 ATP2A3	1.22e-04	29	184	4	GO:1903779
GeneOntologyBiologicalProcess	regulation of muscle system process	FOXO1 CACNA1S ACACB LMCD1 CHRM3 MEF2C RYR2 PPP3CA CACNA1H DMD EP300	1.36e-04	317	184	11	GO:0090257
GeneOntologyCellularComponent	sarcomere	CACNA1S NRAP MYOM1 SYNE1 TRPC1 CAPZB MEF2C RYR2 PPP3CA SQSTM1 SIMC1 SLMAP DMD PALLD	4.70e-08	249	184	14	GO:0030017
GeneOntologyCellularComponent	myofibril	CACNA1S NRAP MYOM1 SYNE1 TRPC1 CAPZB MEF2C RYR2 PPP3CA SQSTM1 SIMC1 SLMAP DMD PALLD	1.47e-07	273	184	14	GO:0030016
GeneOntologyCellularComponent	contractile muscle fiber	CACNA1S NRAP MYOM1 SYNE1 TRPC1 CAPZB MEF2C RYR2 PPP3CA SQSTM1 SIMC1 SLMAP DMD PALLD	3.06e-07	290	184	14	GO:0043292
GeneOntologyCellularComponent	supramolecular fiber	CACNA1S NRAP MYOM1 MAP1B BCAS3 SYNE1 TRPC1 TTLL5 CAMSAP3 CAPZB LCP1 SHROOM2 CLIP1 MEF2C RYR2 FAM83H KRT23 SLC8A2 PPP3CA KIF3B SQSTM1 SIMC1 SLMAP DMD PALLD KIFC1	1.44e-05	1179	184	26	GO:0099512
GeneOntologyCellularComponent	supramolecular polymer	CACNA1S NRAP MYOM1 MAP1B BCAS3 SYNE1 TRPC1 TTLL5 CAMSAP3 CAPZB LCP1 SHROOM2 CLIP1 MEF2C RYR2 FAM83H KRT23 SLC8A2 PPP3CA KIF3B SQSTM1 SIMC1 SLMAP DMD PALLD KIFC1	1.62e-05	1187	184	26	GO:0099081
GeneOntologyCellularComponent	discoidal high-density lipoprotein particle	APOA1 APOM	2.30e-04	3	184	2	GO:0034365
GeneOntologyCellularComponent	sarcolemma	CACNA1S RYR2 SLC8A2 PPP3CA SLMAP CACNA1H DMD ALOX12	2.88e-04	190	184	8	GO:0042383
GeneOntologyCellularComponent	nuclear speck	SFPQ AKAP17A HIPK1 DGKQ TRIP12 MEF2C SLC2A4RG PSME4 BAZ2A ASCC2 PIP5K1A AFDN	4.55e-04	431	184	12	GO:0016607
GeneOntologyCellularComponent	cytoplasmic ribonucleoprotein granule	TDRD9 SYNE1 TNRC6C SQSTM1 EIF4G1 EID1 TNRC6A ANKRD34A CNOT1	6.54e-04	269	184	9	GO:0036464
GeneOntologyCellularComponent	I band	CACNA1S NRAP RYR2 PPP3CA SLMAP DMD PALLD	6.84e-04	166	184	7	GO:0031674
GeneOntologyCellularComponent	transferase complex, transferring phosphorus-containing groups	POLD1 PIK3R3 INSR POLRMT KAT2A REV3L PFKP CCNE1 POLR3D MMS19	8.00e-04	335	184	10	GO:0061695
GeneOntologyCellularComponent	transferase complex	KANSL1L ACACB POLD1 PIK3R3 INSR POLRMT KAT2A REV3L PFKP CCNE1 KANSL3 POLR3D KMT2A OS9 MMS19 DCAF11 KAT14 EP300 MOCS1	8.71e-04	963	184	19	GO:1990234
GeneOntologyCellularComponent	intracellular protein-containing complex	KANSL1L POLD1 POLRMT GATC KAT2A AIP REV3L KANSL3 POLR3D PPP3CA PSME4 EIF4G1 OS9 MMS19 STIP1 DCAF11 CNOT1 KAT14 EP300	9.72e-04	972	184	19	GO:0140535
GeneOntologyCellularComponent	ribonucleoprotein granule	TDRD9 SYNE1 TNRC6C SQSTM1 EIF4G1 EID1 TNRC6A ANKRD34A CNOT1	1.03e-03	287	184	9	GO:0035770
GeneOntologyCellularComponent	dendritic spine	CACNA1S MAP1B SYNE1 CAPZB APBA3 SLC8A2 PPP3CA KIF3B	1.40e-03	242	184	8	GO:0043197
GeneOntologyCellularComponent	histone acetyltransferase complex	KANSL1L KAT2A KANSL3 KAT14 EP300	1.46e-03	94	184	5	GO:0000123
GeneOntologyCellularComponent	neuron spine	CACNA1S MAP1B SYNE1 CAPZB APBA3 SLC8A2 PPP3CA KIF3B	1.59e-03	247	184	8	GO:0044309
GeneOntologyCellularComponent	cell leading edge	FLOT2 PDE4A BCAS3 INSR CAPZB LCP1 CLIP1 STXBP2 KCNC4 PIP5K1A DMD PALLD	1.64e-03	500	184	12	GO:0031252
HumanPheno	Amplification of sexual behavior	GRN TRANK1 PTRHD1	2.54e-05	5	71	3	HP:5200321
HumanPheno	Amplification of social interactions	GRN TRANK1 PTRHD1	2.54e-05	5	71	3	HP:5200212
HumanPheno	Abnormal change in sexual drive	GRN TRANK1 PTRHD1	2.54e-05	5	71	3	HP:0025793
HumanPheno	Abnormal change in social behavior	GRN TRANK1 PTRHD1	5.04e-05	6	71	3	HP:5200243
Domain	Znf-C4pol	POLD1 REV3L	9.34e-05	2	181	2	IPR025687
Domain	M_domain	TNRC6C TNRC6A	9.34e-05	2	181	2	PF12938
Domain	GW182_M_dom	TNRC6C TNRC6A	9.34e-05	2	181	2	IPR026805
Domain	zf-C4pol	POLD1 REV3L	9.34e-05	2	181	2	PF14260
Domain	Ion_trans_dom	CACNA1S TRPC1 RYR2 KCNG2 CATSPER1 KCNC4 CACNA1H	1.23e-04	114	181	7	IPR005821
Domain	Ion_trans	CACNA1S TRPC1 RYR2 KCNG2 CATSPER1 KCNC4 CACNA1H	1.23e-04	114	181	7	PF00520
Domain	PNT	FLI1 ERG ETV6	1.39e-04	11	181	3	PS51433
Domain	SAM_PNT	FLI1 ERG ETV6	1.39e-04	11	181	3	PF02198
Domain	Pointed_dom	FLI1 ERG ETV6	1.39e-04	11	181	3	IPR003118
Domain	SAM_PNT	FLI1 ERG ETV6	1.39e-04	11	181	3	SM00251
Domain	Channel_four-helix_dom	CACNA1S KCNG2 CATSPER1 KCNC4 CACNA1H	2.25e-04	57	181	5	IPR027359
Domain	-	CACNA1S KCNG2 CATSPER1 KCNC4 CACNA1H	2.25e-04	57	181	5	1.20.120.350
Domain	Ago_hook	TNRC6C TNRC6A	2.78e-04	3	181	2	PF10427
Domain	-	POLD1 REV3L	2.78e-04	3	181	2	3.90.1600.10
Domain	DNA_pol_palm_dom	POLD1 REV3L	2.78e-04	3	181	2	IPR023211
Domain	EID	EID2 EID1	2.78e-04	3	181	2	IPR033258
Domain	DNA_POLYMERASE_B	POLD1 REV3L	2.78e-04	3	181	2	PS00116
Domain	TNRC6_PABC-bd	TNRC6C TNRC6A	2.78e-04	3	181	2	IPR032226
Domain	Argonaute_hook_dom	TNRC6C TNRC6A	2.78e-04	3	181	2	IPR019486
Domain	TNRC6-PABC_bdg	TNRC6C TNRC6A	2.78e-04	3	181	2	PF16608
Domain	DNA-dir_DNA_pol_B_CS	POLD1 REV3L	2.78e-04	3	181	2	IPR017964
Domain	DNA_pol_B	POLD1 REV3L	5.53e-04	4	181	2	PF00136
Domain	DNA-dir_DNA_pol_B	POLD1 REV3L	5.53e-04	4	181	2	IPR006172
Domain	DNA-dir_DNA_pol_B_exonuc	POLD1 REV3L	5.53e-04	4	181	2	IPR006133
Domain	DNA-dir_DNA_pol_B_multi_dom	POLD1 REV3L	5.53e-04	4	181	2	IPR006134
Domain	DNA_pol_B_exo1	POLD1 REV3L	5.53e-04	4	181	2	PF03104
Domain	POLBc	POLD1 REV3L	5.53e-04	4	181	2	SM00486
Domain	BROMODOMAIN_2	KAT2A BAZ2A KMT2A EP300	6.53e-04	41	181	4	PS50014
Domain	ZF_ZZ_2	SQSTM1 DMD EP300	6.56e-04	18	181	3	PS50135
Domain	ZF_ZZ_1	SQSTM1 DMD EP300	6.56e-04	18	181	3	PS01357
Domain	ZZ	SQSTM1 DMD EP300	6.56e-04	18	181	3	PF00569
Domain	Bromodomain	KAT2A BAZ2A KMT2A EP300	7.16e-04	42	181	4	IPR001487
Domain	BROMO	KAT2A BAZ2A KMT2A EP300	7.16e-04	42	181	4	SM00297
Domain	-	KAT2A BAZ2A KMT2A EP300	7.16e-04	42	181	4	1.20.920.10
Domain	Znf_ZZ	SQSTM1 DMD EP300	7.74e-04	19	181	3	IPR000433
Domain	ZnF_ZZ	SQSTM1 DMD EP300	7.74e-04	19	181	3	SM00291
Domain	PKNOX/Meis_N	MEIS1 MEIS2	9.16e-04	5	181	2	IPR032453
Domain	Meis_PKNOX_N	MEIS1 MEIS2	9.16e-04	5	181	2	PF16493
Domain	-	KIFBP AIP TRANK1 TMTC3 PDCD11 STIP1 DNAJC3 SMG6	9.47e-04	207	181	8	1.25.40.10
Domain	Haem_d1	COPA KMT2A	1.37e-03	6	181	2	IPR011048
Domain	ACTININ_2	SYNE1 LCP1 DMD	1.37e-03	23	181	3	PS00020
Domain	ACTININ_1	SYNE1 LCP1 DMD	1.37e-03	23	181	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 LCP1 DMD	1.37e-03	23	181	3	IPR001589
Pubmed	Human transcription factor protein interaction networks.	SOX6 FLI1 SIN3B FLOT2 RPL31 ERCC4 ERG ACACB COPA ETV6 DIDO1 GRN KAT2A TNRC6C PFKP MEF2C MPRIP KANSL3 IRF9 LHX2 HNRNPUL2 SQSTM1 NFKBIE EIF4G1 TNRC6A CPSF1 PDCD11 KMT2A STIP1 R3HDM1 CNOT1 KAT14 EP300 ZMYM4 INO80B KIFC1	1.26e-14	1429	189	36	35140242
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	PDE4A SZT2 BCAS3 POLRMT KDM3B TRMT1 DGKQ KAT2A TNRC6C REV3L ARHGEF11 FAM83H MPRIP CCNE1 KANSL3 SLC2A4RG PSME4 AP2A1 NBEAL2 EIF4G1 ANKRD34A CPSF1 PDCD11 LRP5 CACNA1H ATP2A3 D2HGDH EP300 SMG6	2.40e-12	1105	189	29	35748872
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	SIN3B KIFBP PDE4A SFPQ SYNE1 CAMSAP3 DIDO1 PPFIA3 ARHGEF11 CLIP1 LUZP1 MPRIP CCDC13 STOX2 PPP3CA KIF3B AP2A1 HNRNPUL2 KIAA1217 EIF4G1 AFDN STIP1 FRMPD3 CNOT1 SH3BP5 SMG6	1.97e-11	963	189	26	28671696
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	SIN3B AKAP17A POLD1 SYNE1 CAMSAP3 POLRMT ETV6 DIDO1 KAT2A PFKP RAB11FIP1 DDX55 PNKD ARHGEF11 LUZP1 MPRIP BAZ2A SQSTM1 RCL1 EIF4G1 TNRC6A ASCC2 PDCD11 KMT2A OS9 AFDN STIP1 RAP2C ZMYM4 INO80B KIFC1 SMG6	3.32e-11	1497	189	32	31527615
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	FOXO1 FLOT2 MAP1B BCAS3 CAMSAP3 CAPZB KDM3B PFKP RAB11FIP1 TRIP12 LUZP1 FAM83H MPRIP STOX2 SQSTM1 KIAA1217 EIF4G1 KMT2A AFDN R3HDM1 CDC25B DDX41 PALLD WNK4	6.57e-11	861	189	24	36931259
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	MPST FLOT2 POGLUT3 GALNT2 COPA AKAP17A POLRMT KDM3B LANCL1 DIDO1 AIP PFKP RAB11FIP1 DDX55 TRIP12 LUZP1 RHOB PPP3CA TMTC3 AP2A1 SQSTM1 PDCD11 PIP5K1A OS9 MMS19 STIP1 DNAJC3 CNOT1 PALLD	1.10e-10	1297	189	29	33545068
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	RPL31 MAP1B CDK15 GRN AIP PFKP USP9Y PNKD FAM83H CCNE1 STOX2 TRAFD1 SQSTM1 SLMAP KMT2A MMS19 EP300	2.78e-10	432	189	17	23455922
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	FLOT2 SFPQ GALNT2 COPA MAP1B ACADVL SYNE1 INSR CAPZB GRN PFKP TRIP12 FAM83H STXBP2 AP2A1 HNRNPUL2 SQSTM1 EIF4G1 CPSF1 PDCD11 AFDN STIP1 DDX41 CNOT1 KIFC1	4.04e-10	1024	189	25	24711643
Pubmed	A High-Density Human Mitochondrial Proximity Interaction Network.	FLOT2 KIFBP SFPQ COPA ACADVL USE1 SYNE1 TTLL5 POLRMT TRMT1 GATC TACC2 AIP TNRC6C DDX55 SNX19 LUZP1 HNRNPUL2 BAZ2A SQSTM1 KIAA1217 RCL1 SLMAP CPSF1 PDCD11 MMS19 STIP1 R3HDM1 DDX41 SMG6	6.73e-10	1496	189	30	32877691
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLI1 FLT4 SFPQ EVC2 HIPK1 DVL3 KDM3B GRN TRIP12 RYR2 ZNF518A KIF3B AP2A1 SUSD1 EIF4G1 ASCC2 LRP5 OS9 AFDN	7.08e-10	591	189	19	15231748
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	FLOT2 WASHC2C ACACB TTLL5 CAMSAP3 CAPZB GRN AIP TNRC6C LCP1 ARHGEF11 CLIP1 LUZP1 FAM83H STXBP2 KIAA1217 SIMC1 NFKBIE TNRC6A AFDN DDX41 CNOT1	1.82e-09	853	189	22	28718761
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	ACACB POLD1 CAMSAP3 POLRMT USP9Y LCP1 ARHGEF11 TRIP12 TRANK1 TRAFD1 NBEAL2 ASCC2 CPSF1 KMT2A ATP2A3 CNOT1 WNK4	2.32e-09	497	189	17	36774506
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	FOXO1 TOB2 COPA BCAS3 POLD1 EID2 DVL3 KDM3B APBA3 TNRC6C RAB11FIP1 POLR3D TRAFD1 AP2A1 SQSTM1 KIAA1217 NFKBIE RCL1 EID1 DMD R3HDM1 CDC25B CNOT1 SH3BP5	2.71e-09	1038	189	24	26673895
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	WASHC2C COPA CAMSAP3 TRMT1 DIDO1 TACC2 PFKP RAB11FIP1 TRIP12 CLIP1 TRAFD1 HNRNPUL2 SQSTM1 EIF4G1 AFDN PALLD SH3BP5	2.77e-09	503	189	17	16964243
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	TOB2 FLOT2 SFPQ WASHC2C COPA SYNE1 INSR APOA1 TACC2 PNKD CLIP1 FAM83H MPRIP KANSL3 STOX2 AP2A1 HNRNPUL2 SQSTM1 EIF4G1 DCAF11 CDC25B DDX41 CNOT1 ZMYM4 KIFC1	4.62e-09	1155	189	25	20360068
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	FLOT2 RPL31 SFPQ COPA CAPZB POLRMT DIDO1 PFKP DDX55 TRIP12 LUZP1 FAM83H MPRIP AP2A1 HNRNPUL2 SQSTM1 KIAA1217 RCL1 EIF4G1 SLMAP ASCC2 CPSF1 PDCD11 DDX41 ATP4A KIFC1	5.60e-09	1257	189	26	36526897
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	RPL31 SFPQ COPA MAP1B POLD1 CAPZB POLRMT LANCL1 PFKP TRIP12 LUZP1 FAM83H MPRIP PSME4 AP2A1 HNRNPUL2 BAZ2A SQSTM1 MAP4K5 RCL1 EIF4G1 CPSF1 PDCD11 AFDN MMS19 DDX41 PALLD	5.88e-09	1353	189	27	29467282
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	SOX6 ERG GALNT2 COPA AKAP17A HIPK1 SYNE1 TTLL5 ZNF189 DVL3 AIP REV3L USP9Y SHROOM2 TRIP12 MPRIP CCDC13 PPP3CA AP2A1 OTOF EIF4G1 AFDN R3HDM1 EP300 ZMYM4 SH3BP5	8.77e-09	1285	189	26	35914814
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	FOXO1 SIN3B ERG LMCD1 ETV6 DIDO1 ZFP14 TACC2 KAT2A AIP MEF2C MEIS1 MEIS2 LHX2 BAZ2A SQSTM1 NFKBIE KMT2A AFDN	1.36e-08	709	189	19	22988430
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	ERCC4 GALNT2 MAP1B CAMSAP3 POLRMT KDM3B LANCL1 DIDO1 DDX55 PSME4 HNRNPUL2 AACS KMT2A PIP5K1A AFDN CDC25B PALLD KIFC1	2.03e-08	650	189	18	38777146
Pubmed	A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart.	MYOM1 CAPZB CLIP1 MEF2C PPP3CA SLMAP R3HDM1	3.79e-08	60	189	7	19075228
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIFBP SZT2 KDM3B DIDO1 DDX55 KANSL3 STOX2 TRANK1 PSME4 NBEAL2 SLMAP TNRC6A PDCD11 CNOT1 ZMYM4 SMG6	3.86e-08	529	189	16	14621295
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	FLOT2 KIFBP POGLUT3 ACADVL USE1 POLD1 SYNE1 TTLL5 PIK3R3 POLRMT GATC AIP PFKP RAB11FIP1 SNX19 MPRIP TMTC3 BAZ2A MAP4K5 RCL1 SLMAP ASCC2 PDCD11 PIP5K1A OS9 STIP1 DNAJC3	4.14e-08	1487	189	27	33957083
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXO1 SIN3B KIFBP COPA MAP1B BCAS3 HIPK1 POLRMT REV3L TRIP12 MEF2C MEIS1 KANSL3 IRF9 HNRNPUL2 EIF4G1 SLMAP MMS19 EP300 ZMYM4	5.39e-08	857	189	20	25609649
Pubmed	A DDX6-CNOT1 complex and W-binding pockets in CNOT9 reveal direct links between miRNA target recognition and silencing.	TNRC6C EIF4G1 TNRC6A CNOT1	5.81e-08	8	189	4	24768540
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	RPL31 SFPQ ACACB COPA AKAP17A ACADVL POLD1 DVL3 KDM3B DIDO1 LCP1 TRIP12 FAM83H KANSL3 STXBP2 AP2A1 HNRNPUL2 BAZ2A RCL1 EIF4G1 TNRC6A PDCD11 KMT2A STIP1 DDX41	6.06e-08	1318	189	25	30463901
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SIN3B MAP1B CAPZB KDM3B DIDO1 LUZP1 MPRIP BAZ2A NFKBIE PDCD11 KMT2A AFDN CNOT1 PALLD EP300 ZMYM4	6.42e-08	549	189	16	38280479
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLOT2 RPL31 SFPQ COPA MAP1B BCAS3 SYNE1 CAMSAP3 CAPZB PPFIA3 PFKP ARHGEF11 SHROOM2 LUZP1 MPRIP SLC8A2 PPP3CA AP2A1 HNRNPUL2 KIAA1217 EIF4G1 KMT2A AFDN STIP1 DMD CNOT1	7.49e-08	1431	189	26	37142655
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	FLOT2 KIFBP SFPQ GALNT2 COPA MAP1B USE1 POLD1 CAPZB POLRMT PFKP SNX19 CCNE1 LHX2 TRAFD1 HNRNPUL2 SQSTM1 EIF4G1 ASCC2 PDCD11 KMT2A OS9 MMS19 STIP1 DDX41 CNOT1	8.47e-08	1440	189	26	30833792
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	FLOT2 AKAP17A POLD1 PIK3R3 POLRMT KAT2A REV3L PPFIA3 RAB11FIP1 LUZP1 FAM83H ZNF518A TRAFD1 C1orf226 BAZ2A SQSTM1 TNRC6A MMS19 DDX41 KAT14 EP300 INO80B	2.10e-07	1116	189	22	31753913
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	WASHC2C ERG COPA CAMSAP3 KDM3B DIDO1 PFKP TRIP12 CLIP1 KANSL3 TRAFD1 BAZ2A EIF4G1 CPSF1 KMT2A AFDN DDX41 ZMYM4	2.72e-07	774	189	18	15302935
Pubmed	A comprehensive proteomics-based interaction screen that links DYRK1A to RNF169 and to the DNA damage response.	MAP1B CAPZB LUZP1 MPRIP SQSTM1 KIAA1217 EIF4G1 PALLD	2.88e-07	118	189	8	30979931
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	TTLL5 SNX19 LUZP1 AP2A1 SQSTM1 TNRC6A ASCC2 CNOT1 PALLD	4.04e-07	169	189	9	31462741
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	ENPP7 SFPQ HIPK1 INSR KDM3B KAT2A CCNE1 KIF3B AP2A1 KCNC4 KMT2A PIP5K1A PLCB2 CDC25B ATP4A EP300 WNK4	5.82e-07	730	189	17	34857952
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	RPL31 SFPQ COPA GRN TNRC6C PFKP CLIP1 HNRNPUL2 EIF4G1 TNRC6A STIP1 CNOT1 PALLD KIFC1	6.13e-07	494	189	14	26831064
Pubmed	The interactions of GW182 proteins with PABP and deadenylases are required for both translational repression and degradation of miRNA targets.	TNRC6C TNRC6A CNOT1	6.29e-07	4	189	3	23172285
Pubmed	Expression patterns of homeobox genes in the mouse vomeronasal organ at postnatal stages.	MEIS1 MEIS2 LHX2	6.29e-07	4	189	3	27521061
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	SFPQ COPA MAP1B POLRMT DIDO1 PFKP LCP1 TRIP12 BAZ2A RCL1 EIF4G1 CPSF1 PDCD11 KMT2A AFDN CNOT1	6.54e-07	653	189	16	22586326
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	POGLUT3 GALNT2 ACACB USE1 CAPZB RAB11FIP1 LUZP1 FAM83H TRAFD1 PPP3CA TMTC3 MAP4K5 NFKBIE PIP5K1A OS9 R3HDM1 DDX41 DNAJC3 PALLD ZMYM4	6.93e-07	1007	189	20	34597346
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	RPL31 WASHC2C LMCD1 CAPZB DIDO1 TACC2 FUOM SNX19 FAM83H APOM TRANK1 ARSL MAP4K5 HCFC1R1 OS9 MMS19 RAP2C EP300 MOCS1 INO80B IP6K2 SH3BP5	8.70e-07	1215	189	22	15146197
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXO1 WASHC2C HIPK1 TACC2 AIP LUZP1 MPRIP KANSL3 PPP3CA SQSTM1 KIAA1217 TNRC6A STIP1 KAT14 ZMYM4	9.00e-07	588	189	15	38580884
Pubmed	Biological insights from 108 schizophrenia-associated genetic loci.	ERCC4 ASPHD1 KDM3B SNX19 MEF2C TRANK1 PDCD11 PLCB2 CNOT1 EP300 SMG6	9.50e-07	303	189	11	25056061
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	FLOT2 KIFBP RPL31 SFPQ COPA POLD1 SYNE1 TRPC1 CAPZB POLRMT LANCL1 DDX55 AP2A1 HNRNPUL2 SQSTM1 RCL1 EIF4G1 CPSF1 PDCD11 AFDN STIP1 DDX41 CNOT1 KIFC1	9.60e-07	1425	189	24	30948266
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SFPQ ACACB COPA MAP1B ACADVL SYNE1 CAMSAP3 CAPZB KAT2A PFKP LCP1 DDX55 TRIP12 RYR2 LUZP1 KRT23 STXBP2 AP2A1 SUSD1 EIF4G1 KMT2A DMD ATP2A3 DNAJC3	1.18e-06	1442	189	24	35575683
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	RPL31 SFPQ COPA MAP1B POLD1 CAMSAP3 CAPZB GRN AIP PFKP LCP1 LUZP1 RHOB STXBP2 AP2A1 EIF4G1 AFDN MMS19 STIP1 DDX41 CNOT1	1.36e-06	1149	189	21	35446349
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	COPA AKAP17A DIDO1 APOA1 GRN AIP DDX55 TRIP12 CLIP1 LUZP1 MPRIP KANSL3 AP2A1 SQSTM1 RCL1 EIF4G1 TNRC6A ASCC2 CPSF1 PDCD11 KMT2A DDX41 CNOT1	1.76e-06	1371	189	23	36244648
Pubmed	Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome.	SFPQ POLD1 PFKP AP2A1 SQSTM1 EIF4G1	1.80e-06	67	189	6	29357390
Pubmed	Calcium handling precedes cardiac differentiation to initiate the first heartbeat.	MYOM1 MEF2C RYR2 CACNA1H	1.90e-06	17	189	4	27725084
Pubmed	Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer.	RPL31 PDE4A SFPQ MAP1B ACADVL CAPZB POLRMT GRN LUZP1 MPRIP KRT23 AP2A1 SQSTM1 KIAA1217 EIF4G1	1.95e-06	626	189	15	33644029
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	FLOT2 SFPQ COPA MAP1B AKAP17A SYNE1 CAPZB LANCL1 DIDO1 USP9Y DDX55 TRIP12 LHX2 AP2A1 HNRNPUL2 RCL1 EIF4G1 CPSF1 DDX41 CNOT1	2.07e-06	1082	189	20	38697112
Pubmed	Combinatorial transcriptional control in blood stem/progenitor cells: genome-wide analysis of ten major transcriptional regulators.	FLI1 ERG ETV6 MEIS1	2.44e-06	18	189	4	20887958
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	COPA MAP1B BCAS3 DVL3 DDX55 TRIP12 LUZP1 MPRIP SQSTM1 EIF4G1 TNRC6A ASCC2 PIP5K1A R3HDM1 CNOT1 PALLD	2.48e-06	724	189	16	36232890
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	SFPQ ERG KDM3B DIDO1 HNRNPUL2 CPSF1 STIP1 EP300 ZMYM4	3.60e-06	220	189	9	35785414
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	FLOT2 ACACB PIK3R3 INSR RAB11FIP1 MPRIP C1orf226 AP2A1 MAP4K5 KIAA1217 PIP5K1A DMD	3.75e-06	421	189	12	36976175
Pubmed	Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules.	TRPC1 MEF2C RYR2 PPP3CA	3.82e-06	20	189	4	21421818
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	FLOT2 SFPQ WASHC2C ACACB MAP1B ACADVL BCAS3 CAMSAP3 DVL3 TACC2 PPFIA3 SHROOM2 RYR2 HNRNPUL2 SQSTM1 KIAA1217 TNRC6A AFDN STIP1 CNOT1	4.47e-06	1139	189	20	36417873
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	RPL31 COPA MAP1B AKAP17A POLRMT DIDO1 TACC2 DDX55 TRIP12 AP2A1 HNRNPUL2 RCL1 EIF4G1 PDCD11 CNOT1 KIFC1	4.52e-06	759	189	16	35915203
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	FLOT2 RPL31 SFPQ COPA AKAP17A SYNE1 CAPZB PFKP DDX55 LUZP1 MPRIP AP2A1 HNRNPUL2 SQSTM1 CPSF1 PDCD11 DDX41 KIFC1	4.86e-06	949	189	18	36574265
Pubmed	EID-2, a novel member of the EID family of p300-binding proteins inhibits transactivation by MyoD.	EID2 EID1 EP300	5.44e-06	7	189	3	14585496
Pubmed	The transforming acidic coiled coil proteins interact with nuclear histone acetyltransferases.	TACC2 KAT2A EP300	5.44e-06	7	189	3	14767476
Pubmed	Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21.	EID2 CAMSAP3 PFKP EID1	5.72e-06	22	189	4	26631746
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	KIFBP ACACB AIP RAB11FIP1 CLIP1 LUZP1 AP2A1 SLMAP TNRC6A AFDN R3HDM1 CNOT1	6.72e-06	446	189	12	24255178
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	GALNT2 MAP1B BCAS3 PIK3R3 INSR CAMSAP3 ZNF189 TNRC6C SHROOM2 CHRM3 KANSL3 EXD3 PPP3CA KIAA1217 LRP5 PIP5K1A OS9 CACNA1H DNAJC3 CNOT1 EP300 ZMYM4 SMG6	6.86e-06	1489	189	23	28611215
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	POLD1 POLRMT APOA1 AIP FUOM PFKP LCP1 LUZP1 TMTC3 AP2A1 HNRNPUL2 PIP5K1A OS9 AFDN STIP1 DMD CDC25B DNAJC3	6.92e-06	974	189	18	28675297
Pubmed	ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ.	SIN3B RPL31 SFPQ ACACB COPA CAMSAP3 CAPZB TRMT1 DIDO1 PNKD TRIP12 MPRIP TRAFD1 KIFC1	9.09e-06	624	189	14	33729478
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	FLI1 SIN3B SFPQ CAPZB KDM3B ETV6 DIDO1 KAT2A AIP LCP1 DDX55 KANSL3 PPP3CA KMT2A DDX41 CNOT1 EP300 ZMYM4 KIFC1	1.03e-05	1103	189	19	34189442
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MPST COPA MAP1B CAPZB KDM3B KAT2A PFKP TRIP12 SQSTM1 EIF4G1 SLMAP MMS19 STIP1 DCAF11 CDC25B DDX41 CNOT1 ZMYM4	1.06e-05	1005	189	18	19615732
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	SFPQ COPA POLD1 KDM3B ETV6 DIDO1 KAT2A AIP PFKP KANSL3 POLR3D HNRNPUL2 EIF4G1 CPSF1 KMT2A MMS19 DDX41 EP300	1.19e-05	1014	189	18	32416067
Pubmed	Molecular markers of neuronal progenitors in the embryonic cerebellar anlage.	MEIS1 MEIS2 LHX2	1.30e-05	9	189	3	17122047
Pubmed	Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.	RPL31 COPA HIPK1 KAT2A AIP PFKP LCP1 SQSTM1 EIF4G1 STIP1	1.34e-05	327	189	10	15592455
Pubmed	Affinity purification strategies for proteomic analysis of transcription factor complexes.	RPL31 SFPQ HNRNPUL2 CPSF1 PDCD11 DDX41	1.56e-05	97	189	6	23937658
Pubmed	A human MAP kinase interactome.	SFPQ HIPK1 SYNE1 ARHGEF11 MEF2C KRT23 MAP4K5 SIMC1 TNRC6A OS9 DMD EP300	1.58e-05	486	189	12	20936779
Pubmed	Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.	TDRD9 CHRM3 RYR2 TRAFD1 CDC25B	1.63e-05	58	189	5	17554300
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RPL31 SFPQ WASHC2C POLRMT DDX55 TRIP12 LUZP1 MPRIP SQSTM1 RCL1 EIF4G1 CPSF1 PDCD11 KMT2A ZMYM4 INO80B	1.75e-05	847	189	16	35850772
Pubmed	miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT.	TNRC6C TNRC6A CNOT1	1.84e-05	10	189	3	21984185
Pubmed	AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.	CACNA1S RYR2 DMD	1.84e-05	10	189	3	18434328
Pubmed	GCN5 and p300 share essential functions during early embryogenesis.	KAT2A MEF2C EP300	1.84e-05	10	189	3	15937931
Pubmed	A transcriptional inhibitor targeted by the atypical orphan nuclear receptor SHP.	KAT2A EID1 EP300	1.84e-05	10	189	3	11964378
Pubmed	A High-Density Map for Navigating the Human Polycomb Complexome.	SIN3B DIDO1 GRN TRIP12 ZNF518A KANSL3 EIF4G1 KMT2A D2HGDH KAT14 ZMYM4 INO80B	1.89e-05	495	189	12	27705803
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	SIN3B ACACB CAMSAP3 DVL3 POLRMT LUZP1 SQSTM1 TNRC6A CNOT1 KAT14 ZMYM4	2.01e-05	418	189	11	34709266
Pubmed	CRISPR activation screen identifies BCL-2 proteins and B3GNT2 as drivers of cancer resistance to T cell-mediated cytotoxicity.	RPL31 GALNT2 COPA MAP1B CAPZB TRAFD1 SQSTM1 EIF4G1 OS9 MMS19 DNAJC3	2.01e-05	418	189	11	35338135
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	SFPQ POLRMT LUZP1 MPRIP HNRNPUL2 EIF4G1 TNRC6A R3HDM1 DDX41	2.09e-05	274	189	9	34244482
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	POLD1 POLRMT AIP TRIP12 PSME4 SQSTM1 PTRHD1 SLMAP	2.26e-05	212	189	8	33853758
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	DIDO1 ARHGEF11 ZNF518A TRANK1 KIF3B BAZ2A	2.32e-05	104	189	6	9205841
Pubmed	miRNA repression involves GW182-mediated recruitment of CCR4-NOT through conserved W-containing motifs.	TNRC6C TNRC6A CNOT1	2.52e-05	11	189	3	21984184
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	KIFBP RPL31 AKAP17A CDK15 POLD1 CAPZB PFKP RAB11FIP1 MPRIP SQSTM1 EIF4G1 SLMAP AFDN MMS19 STIP1 CDC25B DDX41 ATP2A3 CNOT1 D2HGDH	2.52e-05	1284	189	20	17353931
Pubmed	The HECT type ubiquitin ligase NEDL2 is degraded by anaphase-promoting complex/cyclosome (APC/C)-Cdh1, and its tight regulation maintains the metaphase to anaphase transition.	CAPZB POLRMT DIDO1 GRN ZMAT4 KAT2A RCL1 KMT2A PIP5K1A	2.54e-05	281	189	9	24163370
Pubmed	MAP4K Interactome Reveals STRN4 as a Key STRIPAK Complex Component in Hippo Pathway Regulation.	LUZP1 MAP4K5 SLMAP PIP5K1A STIP1 RAP2C DDX41 CNOT1	2.58e-05	216	189	8	32640226
Pubmed	A Single Adaptable Cochaperone-Scaffold Complex Delivers Nascent Iron-Sulfur Clusters to Mammalian Respiratory Chain Complexes I-III.	MPST KIFBP POLD1 KDM3B GATC LANCL1 TRIP12 TRAFD1 TMTC3 AP2A1 ASCC2 CPSF1 OS9 DDX41	2.59e-05	686	189	14	28380382
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	TMEM202 FLI1 ERG KAT2A PFKP KCNG2 BAZ2A PDCD11 ATP2A3 ZMYM4 INO80B	2.66e-05	431	189	11	33660365
Pubmed	Crosstalk between RyR2 oxidation and phosphorylation contributes to cardiac dysfunction in mice with Duchenne muscular dystrophy.	RYR2 DMD	2.94e-05	2	189	2	26555638
Pubmed	Synergistic Role of Endothelial ERG and FLI1 in Mediating Pulmonary Vascular Homeostasis.	FLI1 ERG	2.94e-05	2	189	2	28248553
Pubmed	Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice.	PPP3CA DMD	2.94e-05	2	189	2	18199592
Pubmed	p62 (SQSTM1) and cyclic AMP phosphodiesterase-4A4 (PDE4A4) locate to a novel, reversible protein aggregate with links to autophagy and proteasome degradation pathways.	PDE4A SQSTM1	2.94e-05	2	189	2	20600853
Pubmed	The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis.	EID1 EP300	2.94e-05	2	189	2	17559085
Pubmed	The Ets family member Erg gene is expressed in mesodermal tissues and neural crests at fundamental steps during mouse embryogenesis.	FLI1 ERG	2.94e-05	2	189	2	10704859
Pubmed	Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition.	FLI1 ERG	2.94e-05	2	189	2	30500808
Pubmed	Transdifferentiation of erythroblasts to megakaryocytes using FLI1 and ERG transcription factors.	FLI1 ERG	2.94e-05	2	189	2	26063314
Pubmed	The ERG-Regulated LINC00920 Promotes Prostate Cancer Cell Survival via the 14-3-3ε-FOXO Pathway.	FOXO1 ERG	2.94e-05	2	189	2	32646965
Pubmed	ERG and FLI1 are useful immunohistochemical markers in phosphaturic mesenchymal tumors.	FLI1 ERG	2.94e-05	2	189	2	26122367
Interaction	TOP3B interactions	PDE4A SZT2 BCAS3 POLRMT KDM3B TRMT1 DGKQ LANCL1 GRN KAT2A TNRC6C REV3L PFKP ARHGEF11 FAM83H MPRIP CCNE1 KANSL3 SLC2A4RG PSME4 AP2A1 NBEAL2 EIF4G1 ANKRD34A CPSF1 PDCD11 LRP5 CACNA1H MMS19 ATP2A3 CNOT1 D2HGDH EP300 SMG6	5.63e-07	1470	186	34	int:TOP3B
Interaction	BTG3 interactions	SYNE1 CAPZB AIP CCDC13 PPP3CA OTOF TNRC6A CNOT1	3.51e-06	98	186	8	int:BTG3
Interaction	CCDC8 interactions	FLOT2 SFPQ GALNT2 COPA MAP1B ACADVL CAPZB GRN PFKP TRIP12 FAM83H RHOB STXBP2 EIF4G1 PDCD11 AFDN STIP1 CNOT1 KIFC1	1.11e-05	656	186	19	int:CCDC8
Interaction	FBXO22 interactions	ACACB POLD1 CAMSAP3 POLRMT USP9Y LCP1 ARHGEF11 TRIP12 TRANK1 TRAFD1 NBEAL2 ASCC2 CPSF1 KMT2A ATP2A3 CNOT1 WNK4	1.14e-05	540	186	17	int:FBXO22
Interaction	YWHAZ interactions	FOXO1 RPL31 SFPQ CAMSAP3 CAPZB LANCL1 TACC2 PPFIA3 PFKP RAB11FIP1 TRIP12 CLIP1 MEF2C LUZP1 FAM83H MPRIP SLC8A2 STOX2 PPP3CA SQSTM1 NBEAL2 SIMC1 ANKRD34A KMT2A AFDN STIP1 R3HDM1 CDC25B EP300	1.14e-05	1319	186	29	int:YWHAZ
Interaction	DYRK1A interactions	FOXO1 SFPQ MAP1B CAPZB DVL3 PFKP TRIP12 LUZP1 MPRIP C1orf226 AP2A1 SQSTM1 KIAA1217 EIF4G1 CNOT1 PALLD EP300	1.51e-05	552	186	17	int:DYRK1A
Interaction	AR interactions	FOXO1 SIN3B FLOT2 SFPQ ERG POLD1 PIK3R3 CAPZB KDM3B DIDO1 RAB11FIP1 CCNE1 KANSL3 HNRNPUL2 SQSTM1 KIAA1217 CPSF1 KMT2A MMS19 STIP1 CDC25B EP300 ZMYM4 KIFC1	1.54e-05	992	186	24	int:AR
Interaction	HDAC6 interactions	FLOT2 RPL31 SFPQ COPA CAPZB ETV6 KAT2A PFKP CLIP1 ZNF518A MPRIP ARSL AP2A1 SQSTM1 EIF4G1 SLMAP CPSF1 AFDN MMS19 STIP1 DDX41 EP300 MOCS1	1.63e-05	929	186	23	int:HDAC6
Interaction	MAD2L1 interactions	FLT4 ERCC4 INSR CAPZB KDM3B ETV6 KAT2A REV3L LUZP1 MAP4K5 KAT14	2.34e-05	252	186	11	int:MAD2L1
Interaction	CNTROB interactions	TNRC6C LUZP1 FAM83H KIAA1217 EIF4G1 SLMAP TNRC6A CNOT1 PALLD	2.44e-05	166	186	9	int:CNTROB
Interaction	NIN interactions	FLOT2 TTLL5 CAMSAP3 CAPZB GRN CLIP1 LUZP1 FAM83H ARSL KIAA1217 TNRC6A AFDN PALLD	3.06e-05	359	186	13	int:NIN
Interaction	BRCA1 interactions	FLI1 RPL31 SFPQ ERCC4 COPA POLD1 CAPZB ETV6 GRN TNRC6C PFKP CLIP1 LUZP1 FAM83H CCNE1 AP2A1 HNRNPUL2 SQSTM1 RCL1 EIF4G1 TNRC6A OS9 STIP1 CNOT1 PALLD EP300 KIFC1	3.20e-05	1249	186	27	int:BRCA1
Interaction	CEP135 interactions	WASHC2C TTLL5 CAMSAP3 DVL3 TNRC6C LUZP1 FAM83H SQSTM1 TNRC6A CNOT1 ZMYM4	4.71e-05	272	186	11	int:CEP135
Interaction	RC3H1 interactions	RPL31 SFPQ CAMSAP3 CAPZB POLRMT TNRC6C DDX55 AP2A1 HNRNPUL2 SQSTM1 RCL1 EIF4G1 TNRC6A PDCD11 PIP5K1A R3HDM1 DDX41 CNOT1	5.84e-05	677	186	18	int:RC3H1
Interaction	CNOT8 interactions	TOB2 CAPZB TNRC6C SQSTM1 TNRC6A CNOT1	6.28e-05	74	186	6	int:CNOT8
Interaction	BAG5 interactions	ACACB COPA MAP1B BCAS3 CAPZB LUZP1 KCNC4 SQSTM1 MMS19 STIP1 PNMA6A CNOT1	8.16e-05	341	186	12	int:BAG5
Interaction	YWHAG interactions	FOXO1 AKAP17A BCAS3 CAMSAP3 CAPZB KDM3B PFKP RAB11FIP1 SHROOM2 TRIP12 LUZP1 FAM83H MPRIP RHOB STOX2 SQSTM1 MAP4K5 SIMC1 EIF4G1 ANKRD34A KMT2A AFDN STIP1 R3HDM1 CDC25B DDX41	8.37e-05	1248	186	26	int:YWHAG
Interaction	TNK2 interactions	MAP1B PIK3R3 CAMSAP3 MPRIP ARSL HNRNPUL2 SQSTM1 AFDN EP300	8.56e-05	195	186	9	int:TNK2
Interaction	YY1 interactions	CAPZB DIDO1 GRN KAT2A TRIP12 KANSL3 LHX2 RCL1 CPSF1 KMT2A KAT14 EP300 ZMYM4 INO80B	8.63e-05	454	186	14	int:YY1
Interaction	BCR interactions	MAP1B APBA3 RHOB AP2A1 SQSTM1 MAP4K5 AFDN DDX41 CNOT1 SMG6	9.35e-05	244	186	10	int:BCR
Interaction	PTP4A3 interactions	KIFBP SFPQ POLD1 PIK3R3 DIDO1 PPFIA3 MPRIP MMS19	9.38e-05	154	186	8	int:PTP4A3
Interaction	OFD1 interactions	KIFBP COPA BCAS3 TTLL5 CAMSAP3 AIP LUZP1 SQSTM1 SLMAP AFDN STIP1 SMG6	9.62e-05	347	186	12	int:OFD1
Interaction	EID1 interactions	CAMSAP3 KAT2A PFKP EID1 EP300	1.06e-04	51	186	5	int:EID1
Interaction	ODF2 interactions	FOXO1 DVL3 TNRC6C LUZP1 FAM83H TNRC6A PALLD INO80B	1.12e-04	158	186	8	int:ODF2
Interaction	SUMO2 interactions	SOX6 ERCC4 WASHC2C COPA POLD1 ETV6 DIDO1 PFKP TRIP12 SIMC1 EIF4G1 MMS19 STIP1 PALLD EP300 ZMYM4	1.24e-04	591	186	16	int:SUMO2
Interaction	EPHA2 interactions	FLOT2 FLT4 ACACB USE1 PIK3R3 INSR ZFP14 RAB11FIP1 MPRIP RHOB C1orf226 AP2A1 MAP4K5 KIAA1217 PIP5K1A AFDN DMD CDC25B	1.25e-04	719	186	18	int:EPHA2
Interaction	TNPO1 interactions	KIFBP MAP1B CAPZB PFKP CLIP1 PPP3CA SQSTM1 TNRC6A STIP1 EP300 KIFC1	1.34e-04	306	186	11	int:TNPO1
Interaction	GPBP1L1 interactions	CAPZB TNRC6C AP2A1 SQSTM1 TNRC6A CNOT1	1.45e-04	86	186	6	int:GPBP1L1
Interaction	PML interactions	FOXO1 SFPQ ERCC4 WASHC2C MAP1B HIPK1 DVL3 KDM3B GRN TACC2 LUZP1 KANSL3 SQSTM1 SIMC1 EIF4G1 KMT2A MMS19 PALLD EP300 MOCS1 ZMYM4	1.50e-04	933	186	21	int:PML
Interaction	WWTR1 interactions	SIN3B MAP1B CAPZB DVL3 DIDO1 LUZP1 MPRIP NFKBIE PDCD11 KMT2A AFDN CNOT1 EP300	1.56e-04	422	186	13	int:WWTR1
Interaction	RTKN2 interactions	CAPZB RHOB SMG6	1.60e-04	12	186	3	int:RTKN2
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	SQSTM1 DMD EP300	2.80e-04	18	131	3	91
GeneFamily	PDZ domain containing	DVL3 APBA3 ARHGEF11 SHROOM2 AFDN FRMPD3	8.43e-04	152	131	6	1220
GeneFamily	ETS transcription factor family	FLI1 ERG ETV6	1.07e-03	28	131	3	534
GeneFamily	Tetratricopeptide repeat domain containing\|Bardet-Biedl syndrome associated\|BBSome	KIFBP TRANK1 TMTC3 STIP1 DNAJC3	1.50e-03	115	131	5	769
Coexpression	DESCARTES_ORGANOGENESIS_CARDIAC_MUSCLE_LINEAGES	ACACB MYOM1 PNKD RYR2 KCNG2 ALPK3 HCFC1R1 DMD SPATS1 RAP2C PALLD	9.38e-08	182	189	11	MM3637
Coexpression	JOHNSTONE_PARVB_TARGETS_3_UP	FLOT2 WASHC2C ACADVL CDK15 DIDO1 GRN SNX19 RHOB KIF3B SQSTM1 EIF4G1 KMT2A AFDN SH3BP5	3.45e-06	433	189	14	M2240
Coexpression	HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL	FOXO1 MAP1B SZT2 INSR TACC2 PPFIA3 PFKP ARHGEF11 CHRM3 SNX19 MEIS1 FAM83H KRT23 PSME4 AACS ATP2A3 PALLD SH3BP5	1.40e-05	775	189	18	M45713
Coexpression	CORONEL_RFX7_DIRECT_TARGETS_UP	TOB2 PIK3R3 REV3L HNRNPUL2 IP6K2	1.60e-05	44	189	5	M42500
Coexpression	LIU_SOX4_TARGETS_DN	SIN3B FLOT2 AKAP17A ETV6 GRN SNX19 FAM83H IRF9 LRP5 MMS19 STIP1	1.68e-05	310	189	11	M17287
Coexpression	BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING	PDE4A POLD1 SYNE1 TRPC1 TRMT1 REV3L MEF2C ZNF518A PPP3CA STXBP2 NBEAL2 EID1 CPSF1 DCAF11	2.00e-05	506	189	14	M253
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	FOXO1 FLI1 FLT4 SFPQ ERCC4 ERG ETV6 LCP1 KMT2A AFDN EP300	2.46e-05	323	189	11	M9150
Coexpression	HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE	SIN3B SFPQ WASHC2C ERG GALNT2 SLC36A4 INSR DVL3 RAD9B GRN RAB11FIP1 TRIP12 MEF2C KRT23 APOM RHOB CCDC13 AP2A1 SQSTM1 NFKBIE RAP2C DNAJC3 INO80B	3.68e-05	1250	189	23	M41099
Coexpression	LAKE_ADULT_KIDNEY_C28_INTERSTITIUM	SYNE1 REV3L MEIS1 MEIS2 KIAA1217 PALLD	3.78e-05	86	189	6	M39247
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN	AKAP17A ACADVL DVL3 TRMT1 DGKQ DIDO1 GRN IRF9 SLFN13 ASCC2 CPSF1 MMS19 PLCB2 D2HGDH EP300	6.07e-05	634	189	15	M40866
Coexpression	GSE11057_CD4_CENT_MEM_VS_PBMC_DN	GALNT2 TDRD9 MEIS1 CATSPER1 STXBP2 SUSD1 OS9 ALOX12	8.97e-05	195	189	8	M3117
Coexpression	GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP	FOXO1 PDE4A SYNE1 GATC DGKQ PLCB2 ATP2A3	9.87e-05	147	189	7	M6765
Coexpression	GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN	FLI1 BCAS3 COL6A5 GRN CLIP1 BAZ2A MMS19 EP300	1.07e-04	200	189	8	M5995
Coexpression	GSE27786_LSK_VS_LIN_NEG_CELL_UP	NRAP CAMSAP3 CLIP1 KANSL3 NBEAL2 NFKBIE PLCB2 SH3BP5	1.07e-04	200	189	8	M4739
Coexpression	GSE17721_CTRL_VS_CPG_6H_BMDC_UP	GATC LANCL1 REV3L PPP3CA STXBP2 BAZ2A CPSF1 HCFC1R1	1.07e-04	200	189	8	M3764
Coexpression	GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP	CACNA1S GATC DIDO1 TNRC6C CLIP1 IRF9 ATP2A3 SH3BP5	1.07e-04	200	189	8	M6447
Coexpression	GSE6875_TCONV_VS_FOXP3_KO_TREG_DN	SLC36A4 SYNE1 EID2 PIK3R3 ETV6 SNX19 MAP4K5 ASCC2	1.07e-04	200	189	8	M6802
Coexpression	GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN	CACNA1S NRAP AIP MEF2C PPP3CA KCNC4 KIAA1217 DMD	1.07e-04	200	189	8	M10033
Coexpression	GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN	FOXO1 ARHGEF11 CLIP1 RCL1 DCAF11 R3HDM1 ZMYM4 SH3BP5	1.07e-04	200	189	8	M9260
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	NRAP MYOM1 TACC2 RYR2 STOX2 PSME4 KIAA1217 SLMAP ALPK3 DMD PALLD	5.74e-10	189	189	11	0a82931b5f6c0a6427ca3edd5e2235ac49099d40
ToppCell	RV-15._Ventricular_Cardiomyocyte_III\|RV / Chamber and Cluster_Paper	NRAP MYOM1 TACC2 RYR2 STOX2 PSME4 SLMAP ALPK3 DMD PALLD	9.31e-09	190	189	10	93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYOM1 MAP1B SYNE1 TACC2 MEF2C RYR2 MPRIP SLMAP DMD PALLD	1.52e-08	200	189	10	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	LPS_IL1RA_TNF-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 PPP3CA KIAA1217 AFDN SH3BP5	1.52e-08	200	189	10	d01cec331be3b03cef80e9536fc531285bcf00f6
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 PPP3CA KIAA1217 AFDN SH3BP5	1.52e-08	200	189	10	a1fa6bae5a688faf488d6925cd3fad725dfa916b
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 PPP3CA KIAA1217 AFDN SH3BP5	1.52e-08	200	189	10	89a6da2bdedc6b1ad0675c8753bf2b763a99af6a
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	VWA3A ENPP7 CDK15 INSR PPFIA3 KANSL3 IRF9 TMTC3	6.46e-08	125	189	8	9e98dcfdc768ae492f453efc08926164bbb0a909
ToppCell	COVID-19-kidney-AQP1+SLC14A1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLI1 ERG LMCD1 PIK3R3 INSR CHRM3 MEF2C MEIS2 ATP2A3	7.72e-08	179	189	9	1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Airway_Smooth_Muscle\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX6 MYOM1 MAP1B LMCD1 RYR2 KCNC4 FRMPD3 DMD PALLD	1.17e-07	188	189	9	61f010c165826b434ca3d27553d4c9e13d2c0c51
ToppCell	droplet-Lung-nan-18m-Mesenchymal-bronchial_smooth_muscle_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SOX6 MYOM1 MAP1B LMCD1 RYR2 KCNC4 FRMPD3 DMD PALLD	1.17e-07	188	189	9	7553ef7de3575af4cf34704b405b551c1af8eb83
ToppCell	Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERG MAP1B MEF2C RYR2 MPRIP KCNC4 CACNA1H DMD MOCS1	1.28e-07	190	189	9	d6b3a92119b210974a32af3fe9875d60eb02761e
ToppCell	COVID-19-kidney-AQP1+PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 ERG LMCD1 INSR CHRM3 MEF2C MEIS2 STOX2 SH3BP5	1.40e-07	192	189	9	27ff3621e177e7932dd44dd6baa81551ea75a874
ToppCell	COVID-19-kidney-Glomerular_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 ERG SYNE1 SHROOM2 CHRM3 MEF2C MEIS2 KIAA1217 SH3BP5	1.53e-07	194	189	9	660535b492445063d965095a50e1e299ce04c50a
ToppCell	COVID-19-lung-Capillary_Aerocytes\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLI1 FLT4 ERG SYNE1 SHROOM2 CHRM3 MEIS1 KIAA1217 SH3BP5	1.67e-07	196	189	9	49cc0a2b9739abad61dff7292ea0b14d28ff35c4
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_only / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 PPP3CA KIAA1217 AFDN SH3BP5	1.99e-07	200	189	9	b1fadb2b5e37e0f51e079d8409c2647eef68dc3b
ToppCell	LPS_anti-TNF-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	1.99e-07	200	189	9	1d105eeda5a2c51f9a4654ffc79b7e2348ad593b
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 LUZP1 PPP3CA KIAA1217 AFDN SH3BP5	1.99e-07	200	189	9	58a7ece7dfdf6c46f2a50cbcb580574dec14c748
ToppCell	LPS_anti-TNF-Endothelial-Endothelial\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	1.99e-07	200	189	9	60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_only / Treatment groups by lineage, cell group, cell type	MYOM1 MAP1B SYNE1 TACC2 MEF2C RYR2 MPRIP DMD PALLD	1.99e-07	200	189	9	7c62678cf408aaaf98d6df0fb27814d2007c4521
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 PPP3CA KIAA1217 KMT2A AFDN SH3BP5	1.99e-07	200	189	9	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Control_saline-Endothelial-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	1.99e-07	200	189	9	e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCell	Control_saline-Endothelial\|Control_saline / Treatment groups by lineage, cell group, cell type	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	1.99e-07	200	189	9	3372c488a39fe812fa94e4f0564594186fea3db5
ToppCell	COVID-19-kidney-Mito-rich_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 ERG SYNE1 INSR CHRM3 MEF2C MEIS2 SH3BP5	2.04e-07	145	189	8	afed661aef990edb8e7012ab67ace56443520c9f
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D122\|Adult / Lineage, Cell type, age group and donor	FLI1 SIN3B FLT4 ERG SYNE1 SHROOM2 MEIS1 KIAA1217	7.16e-07	171	189	8	bd20e85d36fa9d7ddc8afef6a1dea75efc9ee1dc
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG INSR CHRM3 MEF2C MEIS2 SH3BP5	1.01e-06	179	189	8	8f9e538c822940785130297712b75131812a4603
ToppCell	COVID-19-kidney-PLVAP+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLT4 ERG INSR CHRM3 MEF2C MEIS2 KIAA1217 SH3BP5	1.05e-06	180	189	8	493cf8d1a8f2a1ed2672f394a0338b110fd81d88
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SOX6 MAP1B LMCD1 SHROOM2 RYR2 CACNA1H DMD MOCS1	1.10e-06	181	189	8	451b87ac95154bb80018b8dd245b4a6389d81411
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ERG GALNT2 LMCD1 TACC2 REV3L PFKP MEIS1 RYR2	1.15e-06	182	189	8	ed6ae0fd8653f213fe29906a6a4e0729a62e1b75
ToppCell	COVID-19-Heart-CM_4\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRAP MYOM1 TDRD9 MAP1B RYR2 ALPK3 DMD PALLD	1.19e-06	183	189	8	2902b6e8aa9a6f62bc1a792c971ab7f651a8e676
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 MYOM1 MAP1B SYNE1 MEF2C RYR2 DMD PALLD	1.35e-06	186	189	8	4780af76237d7af2abbe2d8d5530cdf53e3ed0b7
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 FLT4 ERG MEF2C MEIS2 LUZP1 KIAA1217 SH3BP5	1.40e-06	187	189	8	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	COVID-19-kidney-VWF+PLVAP+VCAM1+EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLI1 FLT4 ERG INSR MEF2C MEIS2 STOX2 SH3BP5	1.52e-06	189	189	8	c121817ddad164e9cfe382c43d0cbc9215508d02
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Artery\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SOX6 ERG LMCD1 PIK3R3 APOA1 CHRM3 MEF2C MEIS2	1.52e-06	189	189	8	c45734970036e6d28d5e3fe7c9458fae38a3f624
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MYOM1 MAP1B MEF2C MEIS1 MEIS2 RYR2 DMD	1.52e-06	189	189	8	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MYOM1 MAP1B MEF2C MEIS1 MEIS2 RYR2 DMD	1.52e-06	189	189	8	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MYOM1 MAP1B MEF2C MEIS1 RYR2 CACNA1H DMD	1.52e-06	189	189	8	127ad2ba3e794df8cce2eee3e4171bccb5aad51b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MYOM1 MAP1B MEF2C MEIS1 RYR2 CACNA1H DMD	1.52e-06	189	189	8	2cfb4d12f75678d1619f4743838a0e954bd57761
ToppCell	LPS_only-Endothelial-Endothelial-Alv_Cap\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 FLT4 ERG MEIS2 KIAA1217 AFDN CDC25B SH3BP5	1.58e-06	190	189	8	474cbbab8f3b0a6881fa6c92edb78e43999f9ab0
ToppCell	COVID-19-kidney-vSMC/Pericyte\|kidney / Disease (COVID-19 only), tissue and cell type	ERG MAP1B LMCD1 MEF2C MEIS1 MEIS2 MPRIP DMD	1.64e-06	191	189	8	fad8eaa536001b911d05ae2b12150c2398cc6f88
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MAP1B MEIS1 MEIS2 RYR2 CACNA1H DMD PALLD	1.64e-06	191	189	8	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP MYOM1 INSR TACC2 RYR2 ALPK3 DMD PALLD	1.78e-06	193	189	8	dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 FLT4 ERG MEF2C MEIS2 KIAA1217 AFDN SH3BP5	1.78e-06	193	189	8	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 FLT4 ERG MEF2C MEIS2 KIAA1217 AFDN SH3BP5	1.78e-06	193	189	8	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	1.78e-06	193	189	8	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 ERG LMCD1 PIK3R3 INSR MEF2C MEIS2 RYR2	1.85e-06	194	189	8	a429d22c8c9d0fd3bfa9f877a6364cecad68db30
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MYOM1 MAP1B MEF2C MEIS1 MEIS2 RYR2 DMD	1.85e-06	194	189	8	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	NRAP ACACB MYOM1 TACC2 RYR2 SLMAP DMD PALLD	1.85e-06	194	189	8	c3535f7cc0076653c72db582047cff053c322397
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ERG MYOM1 MAP1B MEF2C MEIS1 MEIS2 RYR2 DMD	1.85e-06	194	189	8	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	1.85e-06	194	189	8	a52c5906fce43c2f72cf7e463a3d15cde06431f6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 ERG LMCD1 PIK3R3 INSR CHRM3 MEF2C MEIS2	1.92e-06	195	189	8	6bdef651cf73d7381e5012d0eb3c809138fb6b92
ToppCell	COVID-19-Heart-CM_2\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP MYOM1 INSR TACC2 RYR2 ALPK3 DMD PALLD	1.92e-06	195	189	8	75fc81bddb246dca3b437fb60827b1d4fe416405
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	1.92e-06	195	189	8	23ced69fd904f1d4114b1a7f99f4b5f65ea8824b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG LMCD1 CHRM3 MEF2C MEIS2 SH3BP5	1.99e-06	196	189	8	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG LMCD1 CHRM3 MEF2C MEIS2 SH3BP5	1.99e-06	196	189	8	b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	FLI1 FLT4 ERG INSR MEF2C MEIS1 MEIS2 STOX2	1.99e-06	196	189	8	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG LMCD1 CHRM3 MEF2C MEIS2 SH3BP5	1.99e-06	196	189	8	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	COVID-19-lung-Capillary_Aerocytes\|lung / Disease (COVID-19 only), tissue and cell type	FLT4 ERG SYNE1 SHROOM2 CHRM3 MEIS1 KIAA1217 SH3BP5	1.99e-06	196	189	8	4ac4073380d939a73cec7413e9f3f5ef616d2924
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG LMCD1 CHRM3 MEF2C MEIS2 SH3BP5	1.99e-06	196	189	8	d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ERG LMCD1 SYNE1 MEIS1 MEIS2 MPRIP DMD PALLD	2.07e-06	197	189	8	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	distal-mesenchymal-Vascular_Smooth_Muscle-2\|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	SOX6 MAP1B LMCD1 RYR2 CACNA1H DMD PALLD MOCS1	2.07e-06	197	189	8	da653dc7d216e202f390e5ab0245f243e3ed213b
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	2.15e-06	198	189	8	31ba87552be97c9b78c9e82f98e96699ccb19824
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	MAP1B LMCD1 TACC2 MEF2C RHOB SLMAP PALLD MOCS1	2.15e-06	198	189	8	c9c96066c7fa897b583657f0b77ea093920ae9ba
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	2.15e-06	198	189	8	440af8f90c7afa1c07000806bcf9110b70f489fb
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	2.15e-06	198	189	8	1378c6d4ceb84b42fdd6556be3296df7a8059e6e
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	2.15e-06	198	189	8	451003a21162eeae90739fdb502bb50b362d80c8
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MAP1B SYNE1 ZMAT4 CHRM3 MEF2C RYR2 PPP3CA R3HDM1	2.15e-06	198	189	8	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	COVID-19-kidney-Glomerular_EC\|kidney / Disease (COVID-19 only), tissue and cell type	FLI1 FLT4 ERG SYNE1 CHRM3 MEF2C MEIS2 SH3BP5	2.23e-06	199	189	8	fffd2f9042b55531dac4e5b463b5cee80402e7bb
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate\|Control_saline / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	041a34080120c9f613373c20dcc366292f558040
ToppCell	Control_saline-Endothelial-Endothelial-Gen_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	FLI1 ERG REV3L MEF2C MEIS2 KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	3b97920e1e6e2f09ddba2a861baa9c00c2970f4c
ToppCell	LPS_only-Mesenchymal_myocytic-Pericyte\|LPS_only / Treatment groups by lineage, cell group, cell type	MYOM1 MAP1B SYNE1 MEF2C RYR2 MPRIP DMD PALLD	2.32e-06	200	189	8	8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 PPP3CA KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 PPP3CA KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	3585484c7e24e941708bee471ca607d8ccee74e6
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LMCD1 TACC2 CHRM3 STOX2 KIAA1217 AACS LRP5 ATP2A3	2.32e-06	200	189	8	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	LPS_only-Endothelial-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	4bb609a284d4e6066f17470a1736076aa4a1f84c
ToppCell	LPS_only-Endothelial-Endothelial-Gen_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 PPP3CA KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1
ToppCell	LPS_only-Endothelial\|LPS_only / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	81e76508c9050d533853d5fd2f3097b27613d836
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Artery\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SOX6 ERG APOA1 CHRM3 MEF2C MEIS2 LUZP1 AFDN	2.32e-06	200	189	8	77ae679c35d3b9e2b620f34129f3a8d47e922c65
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MAP1B LMCD1 SYNE1 TACC2 MEIS1 SLMAP DMD PALLD	2.32e-06	200	189	8	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEF2C MEIS2 LUZP1 KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	f15fffefe372005c33e31845982e2d2714ac26af
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MAP1B LMCD1 SYNE1 TACC2 MEIS1 RYR2 DMD PALLD	2.32e-06	200	189	8	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLI1 ERG MEIS2 LUZP1 PPP3CA KIAA1217 AFDN SH3BP5	2.32e-06	200	189	8	b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MAP1B LMCD1 SYNE1 TACC2 MAP4K5 SLMAP DMD PALLD	2.32e-06	200	189	8	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_D\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	VWA3A ENPP7 CDK15 INSR KANSL3 IRF9 ALPK3	2.55e-06	142	189	7	e5608bbbc04edcdaafe1affc4db7f9d8edba04d9
ToppCell	LA-15._Ventricular_Cardiomyocyte_III\|LA / Chamber and Cluster_Paper	NRAP MYOM1 LMCD1 TACC2 RYR2 DMD PALLD	3.20e-06	147	189	7	8970eb6b82589f39439c61a57d999661ec8342de
ToppCell	Control-Myeloid-Monocytes,_Macrophages-Mast-cells\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	LCP1 CHRM3 RAB44 FAM83H EXD3 SUSD1 PLCB2	5.38e-06	159	189	7	81782e9e370558d61af5e0c760ac9759d69fb725
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOA1 LCP1 RAB44 SYCP2 STXBP2 FNDC9 RAP2C	6.33e-06	163	189	7	155ac52a34e0d55545aab8a3e4162fc4c387e697
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-macrophage\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOA1 LCP1 RAB44 SYCP2 STXBP2 FNDC9 RAP2C	6.33e-06	163	189	7	57f02f2b9ce940a2962bb57cd8d02eb67b6f44a3
ToppCell	facs-Limb_Muscle-forelimb_and_hindlimb-18m-Myeloid-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	APOA1 LCP1 RAB44 SYCP2 STXBP2 FNDC9 RAP2C	6.33e-06	163	189	7	c132fb5b56186a10d33ae5ce17b2a7e670d52f79
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ETV6 RAD9B RAB11FIP1 LCP1 FNDC9 FRMPD3 KIFC1	7.13e-06	166	189	7	63dc58864268b4e7779e4c45155022556fc634f9
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ACACB DGKQ GRN RAB11FIP1 ARHGEF11 BAZ2A KAT14	7.42e-06	167	189	7	881f64db8dea3faa7588bf04d87c20924a4e5952
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 MAP1B COL6A5 MEIS1 MEIS2 PALLD SH3BP5	7.71e-06	168	189	7	d19a115365c5415e51c039718d7669de788fcf33
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CCNE1 SUSD1 NFKBIE RCL1 CPSF1 PLCB2 SH3BP5	8.99e-06	172	189	7	76c06a968d3333441eed103abef1e636a1c3e7a1
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLI1 FLT4 ERG ACACB LMCD1 CACNA1H ATP2A3	9.34e-06	173	189	7	0b79e2a4fd19d524c24b69a6b524ffc6affdabe5
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLI1 FLT4 ERG ACACB LMCD1 CACNA1H ATP2A3	9.34e-06	173	189	7	a2c1ef3f4d7e9f68fc77ee7c42a4727bdea5da94
ToppCell	facs-Mammary_Gland-Mammary_Gland-18m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLI1 FLT4 ERG ACACB LMCD1 CACNA1H ATP2A3	9.34e-06	173	189	7	4830136f1f1976e00ac9af9062a531ac42533041
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 ERG SYNE1 CHRM3 MEIS2 IRF9 SH3BP5	9.34e-06	173	189	7	afa6bb19df52541d8d17cbfac9cbdd18a5f3632d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLI1 FLT4 ERG SYNE1 CHRM3 MEIS2 SH3BP5	1.04e-05	176	189	7	dc5a22f9d1347f157bdd93e6e5769b983deccf1a
ToppCell	COVID-19-Heart-CM_3\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRAP MYOM1 LMCD1 RYR2 ALPK3 DMD PALLD	1.04e-05	176	189	7	9df7a124ebafb0087da0cda133a394275d7bed81
ToppCell	Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FLI1 SIN3B FLT4 ERG LUZP1 RHOB SH3BP5	1.21e-05	180	189	7	d8ef44710a77ad0fc03243428e5e1dc4d41200cb
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP MYOM1 LMCD1 TACC2 RYR2 DMD PALLD	1.30e-05	182	189	7	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TOB2 ERCC4 HIPK1 TRPC1 CAPZB CHRM3 LUZP1 PSME4 SQSTM1 EIF4G1 ZMYM4	7.46e-07	195	189	11	3864_DN
Drug	Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; PC3; HT_HG-U133A	FLT4 ASPHD1 MAP1B INSR CAPZB ZMAT4 KANSL3 BAZ2A DCAF11 ATP2A3 ALOX12	8.68e-07	198	189	11	4675_UP
Drug	Adiphenine hydrochloride [50-42-0]; Down 200; 11.4uM; MCF7; HT_HG-U133A	TOB2 HIPK1 TTLL5 INSR GATC PSME4 HNRNPUL2 BAZ2A KMT2A DNAJC3	3.20e-06	183	189	10	1709_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ASPHD1 TTLL5 APBA3 ARHGEF11 CHRM3 RYR2 LHX2 NBEAL2 CPSF1 AFDN	5.38e-06	194	189	10	4804_DN
Drug	Glafenine hydrochloride [65513-72-6]; Down 200; 9.8uM; MCF7; HT_HG-U133A	TOB2 FLOT2 RPL31 ASPHD1 COPA TRPC1 TTLL5 PPFIA3 LHX2 INO80B	5.63e-06	195	189	10	7018_DN
Drug	Mephenytoin [50-12-4]; Down 200; 18.4uM; MCF7; HT_HG-U133A	FLOT2 COPA MAP1B TTLL5 PPFIA3 RYR2 LUZP1 SYCP2 MAP4K5 SMG6	5.63e-06	195	189	10	3580_DN
Drug	Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A	KANSL1L ASPHD1 LMCD1 PIK3R3 ZNF189 GATC TACC2 CHRM3 LUZP1 BAZ2A	5.89e-06	196	189	10	5249_DN
Drug	rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA	KANSL1L TRPC1 PPFIA3 LCP1 ARHGEF11 RYR2 EXD3 ATP2A3 DNAJC3 SMG6	6.16e-06	197	189	10	1013_UP
Drug	Diflorasone Diacetate [33564-31-7]; Up 200; 8uM; PC3; HT_HG-U133A	ERCC4 SYNE1 PIK3R3 INSR DVL3 ETV6 PPFIA3 SYCP2 DCAF11 INO80B	6.16e-06	197	189	10	4077_UP
Drug	Atracurium besylate [64228-81-5]; Down 200; 3.2uM; MCF7; HT_HG-U133A	KANSL1L SIN3B FLT4 ASPHD1 TRPC1 TTLL5 PPFIA3 SHROOM2 LUZP1 IRF9	6.74e-06	199	189	10	1702_DN
Drug	SAHA; Up 200; 10uM; PC3; HT_HG-U133A	FOXO1 LMCD1 ETV6 RAB11FIP1 MEF2C RHOB TRAFD1 INO80B SH3BP5	7.94e-06	160	189	9	1220_UP
Drug	Corynanthine hydrochloride [66634-44-4]; Down 200; 10.2uM; MCF7; HT_HG-U133A	FLOT2 DVL3 GATC AIP SNX19 POLR3D HNRNPUL2 STIP1 INO80B	3.26e-05	191	189	9	4811_DN
Drug	Thalidomide [50-35-1]; Down 200; 15.4uM; MCF7; HT_HG-U133A	KANSL1L ERCC4 ASPHD1 MAP1B TRPC1 PPFIA3 SNX19 IRF9 POLR3D	3.39e-05	192	189	9	5990_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; SKMEL5; HG-U133A	HIPK1 RAB11FIP1 MEF2C LUZP1 PPP3CA HNRNPUL2 EID1 DCAF11 INO80B	3.39e-05	192	189	9	629_UP
Drug	Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; MCF7; HT_HG-U133A	FLI1 ACACB MEF2C RYR2 IRF9 ARSL KMT2A CACNA1H ALOX12	3.53e-05	193	189	9	4146_UP
Drug	chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A	MPST FLOT2 GALNT2 ACACB HIPK1 ARHGEF11 BAZ2A CDC25B EP300	3.68e-05	194	189	9	1217_DN
Drug	Methamphetamine	KIFBP EVC2 WASHC2C ACACB MYOM1 SYNE1 INSR ZNF189 CAPZB TRMT1 TACC2 KAT2A CLIP1 MPRIP CCNE1 RHOB PPP3CA TMTC3 BAZ2A SQSTM1 TNRC6A PIP5K1A STIP1 DMD DNAJC3 PALLD KIFC1	3.81e-05	1401	189	27	ctd:D008694
Drug	Beclomethasone dipropionate [5534-09-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	FLT4 SZT2 TRPC1 DVL3 APBA3 RYR2 IRF9 CACNA1H SMG6	3.99e-05	196	189	9	4403_DN
Drug	Piretanide [55837-27-9]; Down 200; 11uM; MCF7; HT_HG-U133A	ASPHD1 COPA TTLL5 RYR2 LUZP1 IRF9 EXD3 CACNA1H INO80B	3.99e-05	196	189	9	3567_DN
Drug	Bretylium tosylate [61-75-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A	ACACB SYNE1 TTLL5 ARHGEF11 MEF2C BAZ2A CACNA1H R3HDM1 ATP2A3	3.99e-05	196	189	9	3394_UP
Drug	3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A	FLI1 SZT2 SYNE1 TRPC1 APBA3 PPFIA3 MEF2C HNRNPUL2 ATP2A3	4.15e-05	197	189	9	4764_DN
Drug	Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	FLT4 SFPQ ASPHD1 PPFIA3 ARHGEF11 SYCP2 TRAFD1 EID1 INO80B	4.15e-05	197	189	9	6257_DN
Drug	Sulfasalazine [599-79-1]; Up 200; 10uM; PC3; HT_HG-U133A	FLI1 FLT4 ERCC4 ASPHD1 EXD3 BAZ2A HCFC1R1 R3HDM1 INO80B	4.31e-05	198	189	9	6346_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A	KANSL1L FLT4 ACACB SZT2 PPFIA3 NBEAL2 HCFC1R1 CACNA1H MOCS1	4.31e-05	198	189	9	3258_UP
Drug	KB-R7943	CACNA1S SYNE1 TRPC1 SLC8A2 ATP2A3	4.32e-05	47	189	5	CID004534086
Drug	Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A	FOXO1 FLOT2 LMCD1 PPFIA3 IRF9 TRAFD1 NBEAL2 NFKBIE INO80B	4.49e-05	199	189	9	7009_DN
Drug	Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; PC3; HT_HG-U133A	FLI1 FLOT2 FLT4 ERCC4 MAP1B DGKQ APBA3 HCFC1R1 INO80B	4.49e-05	199	189	9	6324_UP
Drug	Xylazine [7361-61-7]; Down 200; 18.2uM; HL60; HT_HG-U133A	KANSL1L SZT2 TTLL5 SYCP2 BAZ2A HCFC1R1 PLCB2 R3HDM1 INO80B	4.49e-05	199	189	9	2132_DN
Drug	Thioguanine	ZNF189 CCNE1 DMD CDC25B ALOX12	6.44e-05	51	189	5	ctd:D013866
Drug	pi u	INSR APOA1 IP6K2	6.47e-05	10	189	3	CID005289159
Drug	Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A	FOXO1 ERCC4 PIK3R3 PPFIA3 MEIS1 MEIS2 BAZ2A NFKBIE	1.02e-04	173	189	8	3464_UP
Drug	potassium	CACNA1S FLT4 ERG POLD1 SYNE1 TRPC1 PIK3R3 RYR2 KCNG2 SLC8A2 CATSPER1 KCNC4 MAP4K5 OS9 AFDN CACNA1H PLCB2 RAP2C ATP2A3 ATP4A WNK4	1.02e-04	1008	189	21	CID000000813
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	KDM3B DIDO1 CLIP1 IRF9 LHX2 POLR3D BAZ2A EP300	1.30e-04	179	189	8	6609_DN
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A	LMCD1 ETV6 RAB11FIP1 MEF2C LUZP1 RHOB TRAFD1 NFKBIE	1.40e-04	181	189	8	5802_UP
Drug	lanthanum	CACNA1S TRPC1 RYR2 CATSPER1 MAP4K5 CACNA1H ATP2A3	1.44e-04	136	189	7	CID000023926
Drug	IAA-94	CACNA1S FLT4 RYR2 CATSPER1 CACNA1H	1.53e-04	61	189	5	CID000003667
Drug	CNS 1145	CACNA1S RYR2 CATSPER1 CACNA1H	1.56e-04	33	189	4	CID000190902
Drug	IHC-64	CACNA1S RYR2 CATSPER1 CACNA1H	1.56e-04	33	189	4	CID000162753
Drug	geldanamycin; Up 200; 1uM; PC3; HT_HG-U133A	KANSL1L FLT4 SZT2 DIDO1 STIP1 DNAJC3 INO80B SH3BP5	1.69e-04	186	189	8	1228_UP
Drug	Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; HL60; HT_HG-U133A	SZT2 APBA3 RAB11FIP1 ARHGEF11 BAZ2A SQSTM1 KMT2A HCFC1R1	1.81e-04	188	189	8	3102_DN
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	TOB2 ERCC4 MAP1B GATC PPP3CA HNRNPUL2 R3HDM1 DNAJC3	1.81e-04	188	189	8	4310_DN
Drug	5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA	FOXO1 KANSL1L TRPC1 DVL3 TRAFD1 CACNA1H MOCS1 SMG6	1.95e-04	190	189	8	970_UP
Drug	LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A_EA	ERCC4 MEIS2 CCNE1 LHX2 NBEAL2 PDCD11 STIP1 ATP2A3	1.95e-04	190	189	8	1016_DN
Drug	Disopyramide [3737-09-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	FLOT2 COPA LANCL1 LCP1 CLIP1 HNRNPUL2 STIP1 ATP2A3	1.95e-04	190	189	8	7439_DN
Drug	Pargyline hydrochloride [306-07-0]; Down 200; 20.4uM; HL60; HG-U133A	COPA ZNF189 GATC REV3L CLIP1 PSME4 EID1 DNAJC3	2.02e-04	191	189	8	1418_DN
Drug	lanatoside C	EVC2 GRN	2.05e-04	3	189	2	CID000003879
Drug	ICI 182,780; Down 200; 0.01uM; PC3; HT_HG-U133A	FLI1 TTLL5 APBA3 ARHGEF11 PLCB2 DCAF11 INO80B SMG6	2.10e-04	192	189	8	4462_DN
Drug	Methantheline bromide [53-46-3]; Down 200; 9.6uM; MCF7; HT_HG-U133A	ASPHD1 TTLL5 HNRNPUL2 NBEAL2 ASCC2 KMT2A EP300 INO80B	2.10e-04	192	189	8	6254_DN
Drug	2-propylpentanoic acid; Up 200; 1000uM; MCF7; HT_HG-U133A	FOXO1 PDE4A ERCC4 ASPHD1 MAP1B TRPC1 DVL3 LUZP1	2.10e-04	192	189	8	1634_UP
Drug	2-propylpentanoic acid; Down 200; 1000uM; MCF7; HT_HG-U133A_EA	FLOT2 COPA USE1 CAPZB KAT2A SNX19 EID1 EP300	2.10e-04	192	189	8	1047_DN
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; HL60; HT_HG-U133A	TOB2 GALNT2 ACACB COPA SZT2 TTLL5 BAZ2A INO80B	2.17e-04	193	189	8	2477_DN
Drug	MS-275; Down 200; 10uM; PC3; HT_HG-U133A	BCAS3 HIPK1 INSR DVL3 ARHGEF11 CLIP1 STIP1 EP300	2.17e-04	193	189	8	7084_DN
Drug	cis-4,7,10,13,16,19-Docosahexaenoic acid ethyl ester; Up 200; 100uM; MCF7; HT_HG-U133A_EA	ERCC4 MAP1B TTLL5 APBA3 CHRM3 LHX2 MOCS1 INO80B	2.17e-04	193	189	8	881_UP
Drug	CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A	TOB2 COPA HIPK1 KAT2A EIF4G1 KMT2A CACNA1H ATP2A3	2.17e-04	193	189	8	3906_DN
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; PC3; HT_HG-U133A	FLT4 APBA3 RYR2 TRANK1 SQSTM1 CPSF1 DNAJC3 INO80B	2.17e-04	193	189	8	1224_UP
Drug	Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A	PDE4A SZT2 SYNE1 TRPC1 PPFIA3 LRP5 DCAF11 EP300	2.17e-04	193	189	8	7364_DN
Drug	Diphenidol hydrochloride [3254-89-5]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TOB2 USE1 TRPC1 POLR3D HNRNPUL2 BAZ2A SQSTM1 INO80B	2.17e-04	193	189	8	7447_DN
Drug	Isoquinoline, 6,7-dimethoxy-1-methyl-1,2,3,4-tetrahydro, hydrochloride; Down 200; 16.4uM; MCF7; HT_HG-U133A	FOXO1 APBA3 CHRM3 TRAFD1 ATP2A3 EP300 MOCS1 INO80B	2.25e-04	194	189	8	2824_DN
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A	FLI1 COPA APBA3 LANCL1 PSME4 HNRNPUL2 CACNA1H ATP2A3	2.25e-04	194	189	8	4736_DN
Drug	Oxyphenbutazone [129-20-4]; Up 200; 12.4uM; PC3; HT_HG-U133A	PIK3R3 INSR ETV6 KANSL3 LHX2 SQSTM1 KMT2A MOCS1	2.25e-04	194	189	8	4506_UP
Drug	Dirithromycin [62013-04-1]; Down 200; 4.8uM; HL60; HG-U133A	TOB2 HIPK1 TRMT1 DIDO1 BAZ2A CPSF1 PDCD11 ATP2A3	2.25e-04	194	189	8	1712_DN
Drug	SC 19220; Up 200; 10uM; PC3; HT_HG-U133A	FOXO1 TOB2 TTLL5 ETV6 PPFIA3 IRF9 HNRNPUL2 BAZ2A	2.25e-04	194	189	8	7065_UP
Drug	Amiodarone hydrochloride [19774-82-4]; Down 200; 5.8uM; HL60; HT_HG-U133A	ACACB SYNE1 TTLL5 TRANK1 TRAFD1 SQSTM1 ZSCAN16 INO80B	2.25e-04	194	189	8	2434_DN
Drug	Loxapine succinate [27833-64-3]; Up 200; 9uM; MCF7; HT_HG-U133A	FOXO1 MAP1B TRPC1 PIK3R3 CLIP1 SQSTM1 ATP2A3 INO80B	2.25e-04	194	189	8	5293_UP
Drug	Flutamide [13311-84-7]; Down 200; 14.4uM; MCF7; HT_HG-U133A	TOB2 HIPK1 EXD3 PSME4 HNRNPUL2 EIF4G1 KMT2A MOCS1	2.25e-04	194	189	8	4361_DN
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	KANSL1L FLI1 TRPC1 TTLL5 ARHGEF11 SHROOM2 ALPK3 R3HDM1	2.33e-04	195	189	8	5977_DN
Drug	Metaraminol bitartrate [33402-03-8]; Down 200; 8.6uM; PC3; HT_HG-U133A	FLOT2 TRPC1 ZNF189 PPFIA3 MEIS1 BAZ2A SQSTM1 NFKBIE	2.33e-04	195	189	8	7368_DN
Drug	Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A	TOB2 RPL31 CAPZB ARHGEF11 LHX2 PSME4 KMT2A AFDN	2.33e-04	195	189	8	3843_UP
Drug	Loracarbef [121961-22-6]; Up 200; 10.8uM; HL60; HT_HG-U133A	USE1 ARHGEF11 LHX2 CPSF1 PDCD11 AFDN PLCB2 DCAF11	2.33e-04	195	189	8	2970_UP
Drug	Etofenamate [30544-47-9]; Down 200; 10.8uM; MCF7; HT_HG-U133A	ERCC4 TRPC1 PIK3R3 PPFIA3 CLIP1 LUZP1 BAZ2A NBEAL2	2.33e-04	195	189	8	7327_DN
Drug	Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A	LMCD1 TRPC1 TTLL5 ARHGEF11 SYCP2 BAZ2A PDCD11 ATP2A3	2.41e-04	196	189	8	7181_DN
Drug	Enalapril maleate [76095-16-4]; Down 200; 8.2uM; PC3; HT_HG-U133A	PDE4A ACACB TRPC1 INSR PPFIA3 RHOB HNRNPUL2 SH3BP5	2.41e-04	196	189	8	7265_DN
Drug	Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A	FOXO1 ACACB COPA GATC RHOB SQSTM1 KMT2A MOCS1	2.41e-04	196	189	8	2086_UP
Drug	Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A	ASPHD1 SZT2 CHRM3 RYR2 CCNE1 BAZ2A PDCD11 DCAF11	2.41e-04	196	189	8	7356_DN
Drug	Clemizole hydrochloride [1163-36-6]; Up 200; 11uM; HL60; HT_HG-U133A	KANSL1L SIN3B RPL31 COPA ETV6 ARHGEF11 CPSF1 DCAF11	2.41e-04	196	189	8	2339_UP
Drug	Oxprenolol hydrochloride [6452-73-9]; Down 200; 13.2uM; MCF7; HT_HG-U133A	KANSL1L FLOT2 PDE4A COPA PPFIA3 LCP1 SYCP2 NBEAL2	2.41e-04	196	189	8	3568_DN
Drug	Gabexate mesilate [56974-61-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	COPA SZT2 PIK3R3 LCP1 LUZP1 DCAF11 ATP2A3 ZMYM4	2.41e-04	196	189	8	7357_DN
Drug	Dequalinium dichloride [522-51-0]; Down 200; 7.6uM; MCF7; HT_HG-U133A	FLOT2 ASPHD1 TTLL5 KAT2A LHX2 BAZ2A LRP5 INO80B	2.41e-04	196	189	8	5396_DN
Drug	Methylprednisolone, 6-alpha [83-43-2]; Down 200; 10.6uM; HL60; HG-U133A	COPA HIPK1 LANCL1 KIF3B MAP4K5 KMT2A STIP1 DNAJC3	2.41e-04	196	189	8	1567_DN
Drug	Propoxycaine hydrochloride [550-83-4]; Up 200; 12uM; PC3; HT_HG-U133A	FOXO1 PDE4A ACACB BCAS3 HIPK1 SYNE1 APBA3 RHOB	2.41e-04	196	189	8	7155_UP
Drug	Riboflavine [83-88-5]; Down 200; 10.6uM; HL60; HG-U133A	COPA LANCL1 CLIP1 MAP4K5 RCL1 ATP2A3 ZMYM4 IP6K2	2.41e-04	196	189	8	1767_DN
Drug	Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; PC3; HT_HG-U133A	FOXO1 ASPHD1 TTLL5 RYR2 SQSTM1 HCFC1R1 DCAF11 DNAJC3	2.41e-04	196	189	8	6338_UP
Drug	Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A	FLI1 TRPC1 PPFIA3 RYR2 LHX2 PSME4 HNRNPUL2 SMG6	2.49e-04	197	189	8	3727_DN
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A	COPA APBA3 ZMAT4 LCP1 LUZP1 POLR3D BAZ2A MOCS1	2.49e-04	197	189	8	3846_DN
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; HL60; HT_HG-U133A	KANSL1L FLI1 COPA INSR GATC KAT2A MEF2C STIP1	2.49e-04	197	189	8	1322_DN
Drug	Trimeprazine tartrate [4330-99-8]; Down 200; 5.4uM; MCF7; HT_HG-U133A	PDE4A ERCC4 PIK3R3 PPFIA3 SYCP2 TRAFD1 ATP2A3 INO80B	2.49e-04	197	189	8	3478_DN
Drug	Neomycin sulfate [1405-10-3]; Down 200; 4.2uM; PC3; HT_HG-U133A	TOB2 RPL31 PDE4A ACACB POLR3D HNRNPUL2 BAZ2A MAP4K5	2.49e-04	197	189	8	5867_DN
Drug	Imidurea [39236-46-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A	GALNT2 AIP PPFIA3 LCP1 MAP4K5 HCFC1R1 DCAF11 INO80B	2.49e-04	197	189	8	5481_DN
Drug	Catechin-(+,-) hydrate [7295-85-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	DVL3 GATC MEIS2 LUZP1 MAP4K5 EID1 DNAJC3 MOCS1	2.58e-04	198	189	8	4837_DN
Drug	Tocopherol (R,S) [10191-41-0]; Down 200; 9.2uM; HL60; HT_HG-U133A	INSR LANCL1 KAT2A MEF2C TRAFD1 RCL1 PLCB2 ZSCAN16	2.58e-04	198	189	8	1320_DN
Drug	haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A_EA	FLOT2 ASPHD1 COPA USE1 INSR LANCL1 BAZ2A INO80B	2.58e-04	198	189	8	1082_DN
Drug	Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	BCAS3 HIPK1 TTLL5 LHX2 POLR3D BAZ2A DNAJC3 SH3BP5	2.58e-04	198	189	8	2054_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; PC3; HT_HG-U133A	TRPC1 APBA3 PPFIA3 POLR3D NFKBIE HCFC1R1 DCAF11 R3HDM1	2.58e-04	198	189	8	7319_DN
Drug	Mycophenolic acid [24280-93-1]; Up 200; 12.4uM; PC3; HT_HG-U133A	KANSL1L RPL31 ERCC4 ASPHD1 ARHGEF11 ARSL HCFC1R1 INO80B	2.58e-04	198	189	8	4019_UP
Drug	Dorzolamide hydrochloride [130693-82-2]; Down 200; 11uM; MCF7; HT_HG-U133A	FOXO1 MPST ERCC4 ASPHD1 PPFIA3 ARHGEF11 SYCP2 POLR3D	2.58e-04	198	189	8	6259_DN
Drug	Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; MCF7; HT_HG-U133A	ASPHD1 GALNT2 PPFIA3 RHOB LHX2 TRAFD1 HNRNPUL2 EID1	2.58e-04	198	189	8	7032_DN
Drug	Artemisinin [63968-64-9]; Down 200; 14.2uM; MCF7; HT_HG-U133A	TOB2 FLOT2 GALNT2 USE1 TRPC1 TTLL5 CCNE1 SQSTM1	2.58e-04	198	189	8	7007_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Down 200; 12.2uM; MCF7; HT_HG-U133A	TTLL5 PPFIA3 LCP1 ARHGEF11 RYR2 LUZP1 SYCP2 MOCS1	2.58e-04	198	189	8	3555_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HG-U133A	ACACB COPA IRF9 EXD3 KMT2A LRP5 ATP2A3 INO80B	2.58e-04	198	189	8	426_DN
Drug	Tribenoside [10310-32-4]; Up 200; 8.4uM; PC3; HT_HG-U133A	FOXO1 FLI1 FLOT2 RYR2 LHX2 NBEAL2 HCFC1R1 INO80B	2.58e-04	198	189	8	6328_UP
Disease	mean reticulocyte volume	SOX6 FOXO1 TOB2 FLOT2 POGLUT3 ERG GATC ETV6 KAT2A AIP LCP1 MEF2C TMTC3 MAP4K5 KIAA1217 RCL1 AFDN CDC25B	1.98e-06	799	179	18	EFO_0010701
Disease	heart disease (implicated_via_orthology)	SOX6 KAT2A RYR2 ATP2A3 CNOT1	3.32e-06	38	179	5	DOID:114 (implicated_via_orthology)
Disease	mean arterial pressure	SOX6 WASHC2C ERG SZT2 INSR TRIP12 CCNE1 PPP3CA STXBP2 KIAA1217 SLMAP TNRC6A SMG6	1.23e-05	499	179	13	EFO_0006340
Disease	mean corpuscular hemoglobin concentration	SOX6 FOXO1 MPST FLOT2 WASHC2C ERG GALNT2 PIK3R3 DVL3 ETV6 LCP1 MEF2C SLC2A4RG SUSD1 MAP4K5 KIAA1217 RCL1 ASCC2 LRP5 PIP5K1A	1.38e-05	1105	179	20	EFO_0004528
Disease	Mitral valve prolapse, response to surgery	LMCD1 ALPK3 SMG6	4.64e-05	12	179	3	EFO_0009951, HP_0001634
Disease	level of Diacylglycerol (18:1_18:2) in blood serum	GALNT2 LCP1 MAP4K5	4.64e-05	12	179	3	OBA_2045171
Disease	apolipoprotein A 1 measurement	GALNT2 ACACB DGKQ APOA1 AIP LCP1 DDX55 MEIS1 IRF9 TRANK1 SLC2A4RG MAP4K5 KMT2A R3HDM1 CNOT1 SMG6	6.43e-05	848	179	16	EFO_0004614
Disease	Mitral valve prolapse	ERCC4 LMCD1 ALPK3 SMG6	6.63e-05	36	179	4	HP_0001634
Disease	triacylglycerol 52:4 measurement	GALNT2 LCP1 MAP4K5 CNOT1	6.63e-05	36	179	4	EFO_0010416
Disease	triacylglycerol 52:3 measurement	GALNT2 LCP1 MAP4K5	9.47e-05	15	179	3	EFO_0010415
Disease	red blood cell density measurement	SOX6 FOXO1 POGLUT3 WASHC2C ERG BCAS3 ETV6 ARHGEF11 MEF2C MEIS1 TMTC3 KCNC4 MAP4K5 RCL1 AFDN SMG6	9.88e-05	880	179	16	EFO_0007978
Disease	Intrahepatic cholestasis of pregnancy	ENPP7 MAP4K5 ATP4A	1.16e-04	16	179	3	EFO_0009048
Disease	Abnormality of the nervous system	ZSCAN16 PALLD	2.18e-04	4	179	2	HP_0000707
Disease	Extra-osseous Ewing's sarcoma	FLI1 ERG	2.18e-04	4	179	2	C0279980
Disease	myeloproliferative neoplasm (is_implicated_in)	ETV6 DDX41	2.18e-04	4	179	2	DOID:2226 (is_implicated_in)
Disease	platelet crit	FOXO1 FLI1 POGLUT3 PDE4A ERG GALNT2 LMCD1 BCAS3 CAPZB PNKD ARHGEF11 MEF2C TRAFD1 MAP4K5 RCL1 SMG6	2.41e-04	952	179	16	EFO_0007985
Disease	neutrophil count	FOXO1 POGLUT3 WASHC2C ERG COPA PIK3R3 PNKD LHX2 KCNG2 TRAFD1 SQSTM1 MAP4K5 NBEAL2 SLMAP TNRC6A ANKRD34A PLCB2 R3HDM1 ZMYM4 SMG6	2.92e-04	1382	179	20	EFO_0004833
Disease	pulse pressure measurement	SOX6 FLOT2 ERG MAP1B TMEM74 INSR LCP1 PNKD SNX19 MEIS1 LUZP1 TRANK1 PPP3CA STXBP2 KIAA1217 TNRC6A ASCC2 CNOT1 PALLD SMG6	3.20e-04	1392	179	20	EFO_0005763
Disease	status epilepticus (biomarker_via_orthology)	GRN MEF2C SLC8A2 KCNC4 DMD	3.67e-04	100	179	5	DOID:1824 (biomarker_via_orthology)
Disease	eye morphology measurement	WASHC2C MAP1B TTLL5 TMEM74 PFKP LUZP1 MPRIP	3.87e-04	218	179	7	EFO_0007858
Disease	platelet-to-lymphocyte ratio	FOXO1 PDE4A ERG GALNT2 MEF2C MEIS1 BAZ2A SQSTM1 RCL1	3.97e-04	363	179	9	EFO_0008446
Disease	Precursor Cell Lymphoblastic Leukemia Lymphoma	ERG ETV6 KMT2A EP300	5.22e-04	61	179	4	C1961102
Disease	monocyte percentage of leukocytes	FOXO1 FLI1 ERG ARHGEF11 MEF2C CCNE1 LHX2 C11orf40 KIF3B SQSTM1 MAP4K5 NFKBIE ZMYM4	5.52e-04	731	179	13	EFO_0007989
Disease	obsolete_red blood cell distribution width	SOX6 MPST GALNT2 BCAS3 INSR TRMT1 LCP1 PNKD CCNE1 SUSD1 SQSTM1 MAP4K5 KIAA1217 SIMC1 RCL1 LRP5 AFDN R3HDM1 EP300	5.68e-04	1347	179	19	EFO_0005192
Disease	cholesterol to total lipids in medium VLDL percentage	GALNT2 LCP1 MAP4K5 STIP1	5.90e-04	63	179	4	EFO_0022239
Disease	cholesteryl esters to total lipids in medium VLDL percentage	GALNT2 LCP1 MAP4K5 STIP1	6.26e-04	64	179	4	EFO_0022253
Disease	reticulocyte count	SOX6 FOXO1 FLOT2 USE1 BCAS3 INSR GATC LCP1 PNKD CLIP1 SUSD1 MAP4K5 RCL1 ASCC2 LRP5 SMG6	6.64e-04	1045	179	16	EFO_0007986
Disease	Leukemia, Myelocytic, Acute	FOXO1 ERCC4 ERG ETV6 KMT2A EP300	6.78e-04	173	179	6	C0023467
Disease	reticulocyte measurement	SOX6 FLOT2 USE1 INSR TRMT1 LCP1 PNKD CLIP1 SUSD1 MAP4K5 RCL1 EIF4G1 ASCC2 LRP5 AFDN SMG6	7.20e-04	1053	179	16	EFO_0010700
Disease	neuropilin-1 measurement	GALNT2 MAP4K5	7.53e-04	7	179	2	EFO_0020603
Disease	Periventricular Nodular Heterotopia	MAP1B TMTC3	7.53e-04	7	179	2	C1868720
Disease	triglycerides to total lipids in very small VLDL percentage	GALNT2 LCP1 MAP4K5 STIP1	8.33e-04	69	179	4	EFO_0022341
Disease	breast cancer (is_marker_for)	BCAS3 INSR KDM3B CCNE1 RHOB ALOX12	9.60e-04	185	179	6	DOID:1612 (is_marker_for)
Disease	restless legs syndrome (implicated_via_orthology)	MEIS1 MEIS2	1.00e-03	8	179	2	DOID:0050425 (implicated_via_orthology)
Disease	level of Triacylglycerol (53:4) in blood serum	LCP1 MAP4K5	1.00e-03	8	179	2	OBA_2045166
Disease	Acute erythroleukemia - M6a subtype	KMT2A DDX41	1.00e-03	8	179	2	C2930975
Disease	Acute myeloid leukemia FAB-M6	KMT2A DDX41	1.00e-03	8	179	2	C2930976
Disease	Acute erythroleukemia - M6b subtype	KMT2A DDX41	1.00e-03	8	179	2	C2930977
Disease	Acute erythroleukemia	KMT2A DDX41	1.00e-03	8	179	2	C2930974
Disease	Ewings sarcoma	FLI1 ERG	1.00e-03	8	179	2	C0553580
Disease	albumin:globulin ratio measurement	FLI1 GALNT2 MPRIP MAP4K5	1.03e-03	73	179	4	EFO_0005128
Disease	docosahexaenoic acid measurement	GALNT2 APOA1 LCP1 MAP4K5 KAT14	1.09e-03	127	179	5	EFO_0007761
Disease	monocyte count	FOXO1 FLI1 ERG SZT2 BCAS3 DIDO1 PNKD MEF2C MEIS1 LHX2 C11orf40 KIF3B TMTC3 SQSTM1 MAP4K5 NFKBIE STIP1 SMG6	1.17e-03	1320	179	18	EFO_0005091
Disease	free cholesterol in small HDL measurement	APOA1 LCP1 MAP4K5	1.25e-03	35	179	3	EFO_0022270
Disease	triglyceride measurement, blood pressure	LCP1 MAP4K5	1.28e-03	9	179	2	EFO_0004325, EFO_0004530
Disease	Behavioral variant of frontotemporal dementia	GRN SQSTM1	1.28e-03	9	179	2	C4011788
Disease	level of Triacylglycerol (51:3) in blood serum	LCP1 MAP4K5	1.59e-03	10	179	2	OBA_2045163
Disease	diacylglycerol 32.2 measurement	LCP1 MAP4K5	1.59e-03	10	179	2	EFO_0020055
Disease	Bladder Neoplasm	VWA3A ERCC4 CCNE1 KMT2A EP300	1.67e-03	140	179	5	C0005695
Disease	degree of unsaturation measurement	GALNT2 LCP1 MAP4K5	1.71e-03	39	179	3	EFO_0022261
Disease	Malignant neoplasm of urinary bladder	VWA3A ERCC4 CCNE1 KMT2A EP300	1.73e-03	141	179	5	C0005684
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	ACACB LCP1 MAP4K5 ATP4A	1.89e-03	86	179	4	EFO_0008595, EFO_0020945
Disease	Diabetic Cardiomyopathies	APOA1 RYR2	1.94e-03	11	179	2	C0853897
Disease	diacylglycerol 34:3 measurement	LCP1 MAP4K5	1.94e-03	11	179	2	EFO_0020059
Disease	triglycerides in large LDL measurement	GALNT2 LCP1 MAP4K5	2.27e-03	43	179	3	EFO_0022319
Disease	prostate cancer (is_marker_for)	FOXO1 KMT2A CDC25B ALOX12 EP300	2.68e-03	156	179	5	DOID:10283 (is_marker_for)
Disease	hypertension (biomarker_via_orthology)	APOA1 CCNE1 SQSTM1 ATP2A3 ALOX12 EP300	2.70e-03	227	179	6	DOID:10763 (biomarker_via_orthology)
Disease	triacylglycerol 54:4 measurement	GALNT2 LCP1 MAP4K5	2.75e-03	46	179	3	EFO_0010422
Disease	amino acid measurement	SOX6 GALNT2 ACACB SYNE1 TACC2 PNKD CHRM3 MEIS2 RYR2 SUSD1 MAP4K5	2.98e-03	678	179	11	EFO_0005134
Disease	platelet measurement	PFKP MEF2C BAZ2A MAP4K5 NBEAL2 RCL1 SMG6	3.22e-03	315	179	7	EFO_0005036
Disease	triglycerides to total lipids in medium LDL percentage	GALNT2 LCP1 MAP4K5	3.49e-03	50	179	3	EFO_0022334
Disease	polyunsaturated fatty acids to total fatty acids percentage	GALNT2 LCP1 MAP4K5	3.49e-03	50	179	3	EFO_0022303
Disease	L2 Acute Lymphoblastic Leukemia	ERG ETV6 KMT2A	3.49e-03	50	179	3	C0023453
Disease	cholesteryl esters to total lipids in IDL percentage	GALNT2 LCP1 MAP4K5	3.49e-03	50	179	3	EFO_0022247
Disease	number of children ever born measurement	ZFP14 MEF2C	3.65e-03	15	179	2	EFO_0009102
Disease	level of Triacylglycerol (53:3) in blood serum	LCP1 MAP4K5	3.65e-03	15	179	2	OBA_2045165
Disease	triglycerides to total lipids in large LDL percentage	GALNT2 LCP1 MAP4K5	3.69e-03	51	179	3	EFO_0022331
Disease	polyunsaturated fatty acids to monounsaturated fatty acids ratio	GALNT2 LCP1 MAP4K5	3.69e-03	51	179	3	EFO_0022302
Disease	high density lipoprotein particle size measurement	GALNT2 DGKQ LCP1 MAP4K5 ATP4A	3.87e-03	170	179	5	EFO_0008592
Disease	lipoprotein measurement	GALNT2 APOA1 LCP1 MAP4K5	3.89e-03	105	179	4	EFO_0004732
Disease	Childhood Acute Lymphoblastic Leukemia	ERG ETV6 KMT2A	3.90e-03	52	179	3	C0023452
Disease	chylomicron measurement, very low density lipoprotein cholesterol measurement	GALNT2 ACACB LCP1 MAP4K5	4.02e-03	106	179	4	EFO_0008317, EFO_0008596
Disease	free cholesterol to total lipids in small LDL percentage	GALNT2 LCP1 MAP4K5	4.12e-03	53	179	3	EFO_0022286
Disease	infantile hypertrophic pyloric stenosis	APOA1 SLMAP	4.15e-03	16	179	2	EFO_0004707
Disease	diabetic retinopathy (implicated_via_orthology)	INSR EP300	4.15e-03	16	179	2	DOID:8947 (implicated_via_orthology)
Disease	diacylglycerol 44:7 measurement	LCP1 MAP4K5	4.15e-03	16	179	2	EFO_0020069
Disease	hepatocellular carcinoma (biomarker_via_orthology)	PIK3R3 INSR CCNE1 EP300	4.30e-03	108	179	4	DOID:684 (biomarker_via_orthology)
Disease	total lipids in medium VLDL	GALNT2 LCP1 MAP4K5	4.34e-03	54	179	3	EFO_0022153
Disease	Peripheral Nervous System Diseases	ERCC4 CACNA1H ALOX12	4.34e-03	54	179	3	C4721453
Disease	Metastatic melanoma	FLT4 ALPK3 WNK4	4.34e-03	54	179	3	C0278883
Disease	retinal vasculature measurement	SOX6 ERCC4 ERG TTLL5 MEF2C LUZP1 R3HDM1 PALLD MOCS1	4.48e-03	517	179	9	EFO_0010554
Disease	triglycerides in medium VLDL measurement	GALNT2 LCP1 MAP4K5	4.57e-03	55	179	3	EFO_0022155
Disease	behavior	ZMAT4 LCP1 MEIS2	4.57e-03	55	179	3	GO_0007610
Disease	phospholipids in medium HDL measurement	GALNT2 LCP1 MAP4K5	4.57e-03	55	179	3	EFO_0022295
Disease	cholesteryl ester measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	GALNT2 ACACB LCP1 MAP4K5	4.59e-03	110	179	4	EFO_0008317, EFO_0008596, EFO_0010351
Disease	free cholesterol measurement, chylomicron measurement, very low density lipoprotein cholesterol measurement	GALNT2 ACACB LCP1 MAP4K5	4.59e-03	110	179	4	EFO_0008317, EFO_0008591, EFO_0008596
Disease	chylomicron measurement, total cholesterol measurement, very low density lipoprotein cholesterol measurement	GALNT2 ACACB LCP1 MAP4K5	4.59e-03	110	179	4	EFO_0004574, EFO_0008317, EFO_0008596
Disease	vascular endothelial growth factor measurement	EVC2 CHRM3 MEF2C	4.81e-03	56	179	3	EFO_0004762
Disease	triglycerides in large VLDL measurement	GALNT2 LCP1 MAP4K5	4.81e-03	56	179	3	EFO_0022178
Disease	triglycerides in LDL measurement	GALNT2 LCP1 MAP4K5	4.81e-03	56	179	3	EFO_0022320
Disease	triglycerides in very large VLDL measurement	GALNT2 LCP1 MAP4K5	4.81e-03	56	179	3	EFO_0022325
Disease	triglycerides to total lipids in medium HDL percentage	GALNT2 LCP1 MAP4K5	4.81e-03	56	179	3	EFO_0022333
Disease	triglycerides in chylomicrons and extremely large VLDL measurement	GALNT2 LCP1 MAP4K5	4.81e-03	56	179	3	EFO_0022316
Disease	Alzheimer's disease (is_marker_for)	ACADVL INSR APOA1 SLC8A2 KCNC4 EP300	4.95e-03	257	179	6	DOID:10652 (is_marker_for)
Disease	Hypertrophic Cardiomyopathy	MYOM1 RYR2 ALPK3	5.05e-03	57	179	3	C0007194
Disease	low density lipoprotein cholesterol measurement, lipid measurement	GALNT2 APOA1 LCP1 MAP4K5	5.21e-03	114	179	4	EFO_0004529, EFO_0004611
Disease	Beta blocking agent use measurement	SOX6 BCAS3 INSR SMG6	5.21e-03	114	179	4	EFO_0009929
Disease	very low density lipoprotein cholesterol measurement	GALNT2 ACACB INSR LCP1 TRAFD1 MAP4K5	5.23e-03	260	179	6	EFO_0008317
Disease	migraine disorder, systolic blood pressure	STXBP2 SMG6	5.25e-03	18	179	2	EFO_0006335, MONDO_0005277
Disease	triglycerides in IDL measurement	GALNT2 LCP1 MAP4K5	5.30e-03	58	179	3	EFO_0022149

Protein segments in the cluster

Peptide	Gene	Start	Entry
EKRMQEFRSSDGRPD	AFDN	231	P55196
VRSARDDMDRGKPDK	SMG6	366	Q86US8
RDRISPEGLEKMAQL	SMG6	601	Q86US8
DPAALKDRRMENLVA	EP300	596	Q09472
EGSTDLRTEGRPDMK	APOM	106	O95445
LRTEGRPDMKTELFS	APOM	111	O95445
MRTPNIDRLAEDGVK	ARSL	61	P51690
RAAEPKEVASEGTML	CATSPER1	706	Q8NEC5
MDAALKRSRSEEPAE	SH3BP5	1	O60239
MSKEERPGREEILEC	AACS	1	Q86V21
AKRTGRSEVEMEGPE	BAZ2A	1021	Q9UIF9
DPAVLREKAEARRMA	ASCC2	681	Q9H1I8
NGEFKMTDPDEVARR	ERG	336	P11308
EIVAGLEKMPARRAS	GRN	421	P28799
AKLVREVAAPDVGRM	FLOT2	131	Q14254
VPEEELGMVDLERKA	CHRM3	391	P20309
RKASMLEVPRAEEEL	ALPK3	1421	Q96L96
AREAMDRVKAPDGET	APBA3	246	O96018
KAENVPRSRSDVDMD	ARHGEF11	626	O15085
DLMLARFDGPAREEL	ARHGEF11	811	O15085
DPDEEMAKIDRTARD	CCNE1	41	P24864
REMGEAFAADIPRIL	AP2A1	141	O95782
RFEKPRMDDGLLEVV	DGKQ	836	P52824
PEVAAMARLLGDLDR	COMMD5	31	Q9GZQ3
LQEKLSPLGEEMRDR	APOA1	161	P02647
KTEERTRKMEEEPLG	DMD	466	P11532
VKAMASPESGLEVRD	DVL3	416	Q92997
EGLRERLADAMAESP	BCAS3	856	Q9H6U6
GAMPSARLRKLEVEA	CAPZB	86	P47756
MDDLDKVLRPRAAGS	CAMSAP3	991	Q9P1Y5
DIAAAKEVLSDPEMR	DNAJC3	441	Q13217
TRDAPPRKEDMELDD	ATP2A3	566	Q93084
EGTVLDDSRARGKPM	AIP	46	O00170
DDSRARGKPMELIIG	AIP	51	O00170
GRGMLSPRAQEEEEK	ANKRD34A	196	Q69YU3
DGESFELKIVRRGMP	RCL1	146	Q9Y2P8
ELPDGITRMEAEKLF	R3HDM1	991	Q15032
EPEREVMSSEGRALA	RAP2C	121	Q9Y3L5
RAESRLEDPGMDSRE	RAB44	796	Q7Z6P3
TLEDAKRLRVMGDIP	KAT2A	441	Q92830
MPIDLVIDDREGGSK	MEIS1	181	O00470
PAMKRVDGDVSEVSE	RAD9B	341	Q6WBX8
LRASEMARAEGIPKI	ACACB	1811	O00763
KTPDEIMSGRTDRLE	ETV6	421	P41212
ERRAFPLKGEDMAAL	KANSL1L	916	A0AUZ9
ERRKRFGMLDATDGP	MPRIP	591	Q6WCQ1
GTEDAALRMEVDRSP	MPRIP	606	Q6WCQ1
AIGPAKELEAERSLM	MAP1B	816	P46821
RLRAVDTDGVEPMES	GATC	66	O43716
QMERGLKSADPRDGT	LANCL1	46	O43813
RAMDVEPRAKGVLLE	IP6K2	6	Q9UHH9
PEIVRMVEARKSLGE	NRAP	141	Q86VF7
LEGTDMLAEKADRRE	HIPK1	476	Q86Z02
MDGEKDPRNLLVAFR	MMS19	181	Q96T76
VEMPRKNSRDGAELD	FNDC9	181	Q8TBE3
EKDLRGVTPDSAEML	PPFIA3	1136	O75145
GKMPIDLVIDERDGS	MEIS2	181	O14770
ERGPRKERETAQSGM	ASPHD1	11	Q5U4P2
RAAGMSEARKGPDEA	NFKBIE	136	O00221
QVESDKLRMDRAIPD	GALNT2	106	Q10471
EAMGVVLRGDRDKPR	LRP5	1056	O75197
TPGRLEDMFRRKAEG	DDX55	141	Q8NHQ9
SGSRLKRRPDQMEDG	KIFC1	31	Q9BW19
RIPRMTGEEKEFETI	CPSF1	1046	Q10570
ADKMFLRTREPALDG	EID1	131	Q9Y6B2
PAVVIDMSGLREKDD	LCP1	316	P13796
LSTMPDIRAEEERGE	KCNG2	196	Q9UJ96
MDADDSRAPKGSLRK	PFKP	1	Q01813
ERADAMDTSDRPGLR	PDE4A	66	P27815
RASRNPVESAMELKE	KAT14	246	Q9H8E8
DRRTMREDDPKPVGA	DCAF11	336	Q8TEB1
RKEVEGDDVPESIML	HNRNPUL2	576	Q1KMD3
KSRPRSETEEMGDEE	KDM3B	1061	Q7LBC6
TGPREDLIKVLEDMR	KRT23	231	Q9C075
AMEEAEELLKRAGER	EVC2	476	Q86UK5
RKMEVEELSPLALGR	CDC25B	241	P30305
DEMDRRAKSEAPAIS	LHX2	16	P50458
ERESPSVKRMRLSEG	MEF2C	456	Q06413
SARTMPEAKADDIVG	INSR	841	P06213
TIAADRKDDLPPNMR	ALOX12	151	P18054
MEESEPERKRARTDE	DDX41	1	Q9UJV9
VREAFPGDSKSMVRE	MMEL1	456	Q495T6
MEEQPECREEKRGSL	HMHB1	1	O97980
SGIKRPMASEVLEAR	PIP5K1A	31	Q99755
SDLEDDRKIGRLLMD	LMCD1	61	Q9NZU5
DSEGRAAMVDVGRKP	MOCS1	486	Q9NZB8
AAMVDVGRKPDTERV	MOCS1	491	Q9NZB8
PALTEEMLLKREERA	INO80B	206	Q9C086
DQGEMEREVKSPGAR	PALLD	226	Q8WX93
NDKLRDMPDGTFLVR	PIK3R3	76	Q92569
AAVMELVPSDKERGL	FUOM	76	A2VDF0
EKLPSDLDGMFIERL	FOXO1	596	Q12778
EDLASQMLKGFPRDR	CDK15	361	Q96Q40
EIMATELLKGREAPE	CACNA1S	1826	Q13698
QPEATMEREERGKVL	C1orf226	176	A1L170
DGGMIVFKLERERPA	COPA	311	P53621
LGMLPREAKEVEASL	FRMPD3	1451	Q5JV73
TDGMSTDRVVEPAKR	COL6A5	551	A8TX70
MGDRALLETPEVKAL	CCDC13	196	Q8IYE1
NGEFKMTDPDEVARR	FLI1	306	Q01543
RPANSGELDKMDEKR	DIDO1	1201	Q9BTC0
MDEKRTRLQPEEADV	DIDO1	1211	Q9BTC0
ETARVDGLMKREETP	DRC7	531	Q8IY82
REARMAEVARLLGEP	EID2	101	Q8N6I1
KEMDEAATAEERGRL	EIF4G1	866	Q04637
AEAERMADGPLKDRP	LUZP1	856	Q86V48
SSEFKEVPERGRMDV	IRF9	91	Q00978
RGDVDDPLLDMKTPV	KANSL3	386	Q9P2N6
AVALGRKRAVFPDDM	KMT2A	1076	Q03164
RGAVPMSTKRRLEEE	HCFC1R1	36	Q9NWW0
QLLSPKGERRMEDEG	FAM83H	971	Q6ZRV2
TPNLDAMARDGVKAR	ENPP7	51	Q6UWV6
MTEGARAADEVRVPL	CACNA1H	1	O95180
SEKERPEEQGPRMAF	RYR2	4221	Q92736
RPTEMGLDLEESLRK	SLFN13	71	Q68D06
PLRKRLAFAEEVMDD	POLRMT	856	O00411
VELAERMRKRDPGSA	POLD1	901	P28340
EEAKGLDRINERMPP	PPP3CA	471	Q08209
LVEMKGGDRVPADIR	ATP4A	201	P20648
GEDVLRPAMLAKFRV	KIFBP	536	Q96EK5
RRLESNKPAGDVDMS	CLIP1	531	P30622
VEERDFIMPLDLGAK	D2HGDH	181	Q8N465
PPLRKETEARDEMGL	MAP4K5	346	Q9Y4K4
FLEASMIDRRNGDKP	OTOF	616	Q9HC10
SMEEGAEPRERAILA	SZT2	1371	Q5T011
KDTPLFRMEGEDALV	RAB11FIP1	906	Q6WKZ4
LARMKQEPVRTDDGR	RHOB	131	P62745
RMLEKDDFLDDPGLR	POLR3D	156	P05423
RPGGKAADEAMEERR	TRMT1	566	Q9NXH9
PSIRRKMEIDDGTSA	TNRC6C	716	Q9HCJ0
MRARPEDVISEGRGK	MPST	281	P25325
AGVVEPENLARERKM	PNKD	301	Q8N490
GRMRKVVLEAPDETT	PTRHD1	76	Q6GMV3
SPEDVKRRAMADPEV	STIP1	481	P31948
PRSLSDIKGAADEIM	TRAFD1	276	O14545
LERGEAKASSPEMDI	SYNE1	1671	Q8NF91
DPKLVMEQADRESSR	TDRD9	1351	Q8NDG6
MFRLSRELLDEKGPE	NBPF20	1	P0DPF2
PLGKSSEERMERNAV	NBEAL2	936	Q6ZNJ1
AILERRDVKPDEDMS	KIAA1217	366	Q5T5P2
IDARKEMTPRQEGTD	KIAA1217	1416	Q5T5P2
ASGEDLRKLPTMAEV	SIMC1	6	Q8NDZ2
EGRREKGSDPAMELR	SIN3B	821	O75182
MEGAEPRARPERLAE	SHROOM2	1	Q13796
PSDRDRLRSEVKAGM	OS9	446	Q13438
DPDGLKKESERDRAM	OS9	476	Q13438
MRKIALESEGRPEEQ	SQSTM1	311	Q13501
TEPLDEALRKLRMAG	PNMA6A	296	P0CW24
KPDEGSRDREIMTSV	SOX6	101	P35712
GFMKEPGVERVLRDL	ACADVL	441	P49748
FRDAKDMNETLPGER	AKAP17A	131	Q02040
EREPKLSILQMDRGD	C11orf40	11	Q8WZ69
GPEMDKRLATEFELR	CNOT1	1516	A5YKK6
EIAKAELDDTPMRGR	SFPQ	346	P23246
SDEPLDKRGLLEERM	TRPC1	291	P48995
RQSSKPEVRDGMELV	POGLUT3	471	Q7Z4H8
LGTDSAEPEMDVRKR	USE1	126	Q9NZ43
KELSRIEEALMDPGR	PDCD11	1586	Q14690
RIKSEIDQDPMGRET	ZNF189	86	O75820
KINPRGESEAMPRED	VSIG1	281	Q86XK7
EMGTPDVRIDTRLNK	RPL31	56	P62899
PTDPRAEEIMAAAEK	REV3L	1131	O60673
TPGKARLDEVMAAAA	SLC2A4RG	96	Q9NR83
VPEKRDSGMTEVERT	SPATS1	31	Q496A3
EDLRREKDAAEMLGA	KIF3B	451	O15066
DVSGELAKRRTEMPF	STOX2	441	Q9P2F5
KLFLPDGMEARLRSD	SLMAP	126	Q14BN4
IKGQRLDPMESVREE	SUSD1	331	Q6UWL2
EMEEKGERRANLLPK	SYCP2	1301	Q9BX26
EGPEKTRSQLLIMDR	STXBP2	221	Q15833
EKSPEQRGRFRAMVE	FLT4	951	P35916
RIKGDAMGRVDEEPT	WASHC2C	296	Q9Y4E1
KEMAGVPPTLREDER	TACC2	1516	O95359
LIRRLAEDDKDGVMA	USP9Y	491	O00507
DVRDSEKMPRISGFG	ZNF518A	871	Q6AHZ1
EQPKLGRSREDMTEA	PSME4	1291	Q14997
LPLGNMDSDRVEARK	SNX19	616	Q92543
SPAARAGAREEAMKE	PLCB2	866	Q00722
AGAREEAMKEAAEPR	PLCB2	871	Q00722
PGNSERRDILMDKLA	ZSCAN16	131	Q9H4T2
TLLDEERKEPGMVVR	ZFP14	56	Q9HCL3
EKASMVVPEEREGRD	ERCC4	636	Q92889
PNTVAAREMERLEKE	TMEM74	206	Q96NL1
VMQESGEVKLRPEAR	TMTC3	641	Q6ZXV5
DKAVEMRTGDSDPRV	TRANK1	1261	O15050
GPRSEMESLSVREKN	TMEM202	251	A6NGA9
GAAEARRQEKMADPE	TRIP12	346	Q14669
GEMVDPVVELAAKRS	TOB2	61	Q14106
TLLKRDTGPMEAAED	WNK4	746	Q96J92
PAKRLRSENGSDADM	ZMAT4	56	Q9H898
TPAAAGAARREELDM	SLC36A4	6	Q6YBV0
SPESIRRKMEIDDGT	TNRC6A	991	Q8NDV7
MAEREVESGPRKRFE	ZMYM4	1	Q5VZL5
DRMTADGAPELKIES	TTLL5	516	Q6EMB2
GARMSIKDDPDREKS	VWA3A	761	A6NCI4
PAREEGMIERKRADS	KCNC4	526	Q03721
EARRIAEMGKPVLGE	SLC8A2	641	Q9UPR5
DLRAETPDMLADGTR	EXD3	796	Q8N9H8
PEEEARMAALESLKG	MYOM1	1666	P52179